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Introduction 
It is generally accepted that for autonomous hyperparathyroidism, whether 
primary or tertiary, surgery is still the only suitable method of treatment 
available. Analysis of a series of cases treated in t his way over the past 
twenty years has shown that there are certain problems associated with the 
treatment of this disease that have not yet been solved. 
Even experienced surgeons may have difficulty in finding the parathyroid 
glands when the localization or number is abnormal. The histological differ-
entiation between nodular hyperplastic, and adenomatous parathyroid 
tissue may be extremely difficult, sometimes even impossible. It is just this 
difference that might determine the amount of resection and the post-
operative course. Furthermore, in some cases it is exceedingly difficult for 
the surgeon to judge whether a parathyroid is of normal size and has a 
normal appearance. Lastly, the etiology of primary hyperparathyroidism 
is still unknown. 
In the present work the findings in 267 patients treated surgically be-
tween 1950 and 1970 are discussed and evaluated in relation to the data in 
the literature. Special attention is paid to the etiology of the disease, the 
histological picture, and the surgical technique. The symptomatology, 
diagnosis, and biochemical changes will only be mentioned briefly, since 
the problems associated with them are so numerous that they deserve 
separate treatment. A thesis on these subjects is in preparation in Leiden. 
Because the prognosis of associated disease, especially the renal, is the 
more favourable the earlier the diagnosis is made, some principles are given 
to promote earlier consideration of the diagnosis hyperparathyroidism in 
cases with few symptoms. 
The data of 267 patients who underwent an operation between 1950 and 
1970 under the probability diagnosis hyperparathyroidism are discussed. 
These patients were treated in the Leiden University Hospital, the Leiden 
Diaconess Hospital, or the Rotterdam University Hospital. In 255 of t hese 
cases the diagnosis was confirmed at surgery and histologically. 
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Chapter I - Historical review 
In 1871 von Recklinghausen described certain pathological changes in bone 
which he termed fibrocytsche Osteitis mit multiplen Osteosarcomen. He did not, 
however, distinguish between the local and systemic forms of this disease. 
In 1910 he reported on the simultaneous occurrence of nephrocalcinosis, 
but without having seen the relationship between the renal anomalies and 
the bone disease. 
The human parathyroid glands were first found by Sandstrom in 1880. 
Their function was only partially understood by Vassale and Generali (1896), 
although they ascribed the tetany seen after thyroidectomy in part to the 
unintentional removal of the parathyroid glands. Erdheim (1906) demon-
strated that the tetany was the result of the parathyroidectomy and had 
nothing to do with the thyroidectomy, as had originally been thought. He 
also described changes in the teeth of parathyroidectomized rats, and 
inferred a relationship between parathyroid gland function and bone 
formation. Halstead (1907) attempted unsuccessfully to correct the hypo-
parathyroidism seen after thyroid gland operations by heterologous para-
thyroid gland transplantations. 
An important contribution to the understanding of the biochemical 
changes accompanying parathyroidectomy and the subsequent tetany was 
made in 1909 by MacCallum and Voegtlin, who showed that in dogs the 
calcium level in the blood dropped after parathyroidectomy and that the 
clinical picture improved after the addition of extra calcium to the diet. 
Meanwhile, Askanazy (1904, 1906) suggested with some hesitation that 
there might be a relationship between the occurrence of parathyroid gland 
tumors and decalcification of the bone, but in this period the pathogenetic 
relationship was not recognized. In 1915 Schlagenhaufer and Maresch re-
commended parathyroidectomy for the treatment of osteitis fibrosa. 
Nothing at all was known about the difference between primary and 
secondary hyperparathyroidism, i.e. the difference between autonomous 
hyperfunctioning and compensatory hyperplasia of the parathyroid glands. 
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(In the former there is a hyperfunction of the parathyroid glands causing 
hypercalcemia and in the latter the compensatory hyperplasia occurs as a 
reaction to chronic hypocalcemia.) 
It was thought that enlargement of one or more parathyroid glands was 
evidence of inadequate functioning of these glands. It was also assumed 
that there was an additional influence of the thyroid gland on the calcium 
metabolism, because of the greatly feared tetany after thyroidectomy, 
Despite Erdheim's publications it was not realized that this tetany was 
caused by parathyroidectomy. This inadequate understanding of the 
function of the parathyroid glands formed a serious impediment for para-
thyroid surgery. We may cite as characteristic of the 'European' conception 
of and approach to the clinical picture, the treatment of the patient with 
osteitis fibrosa by Mandl (1925), who approached the problem according to 
the old ideas concerning the histological picture, i.e. via the relationship 
between the bone anomalies and the presence of neoplastic parathyroid 
glands with inadequate function. 
The patient (Albert J .) was a 38 year old conductor who complained 
of fatigue and of pain in the bones. In 1924 osteitis fibrosa was diagnosed 
radiographically, and he was treated with thyroid and parathyroid prepa-
rations orally to supplement an assumed deficiency. His condition never-
theless continued to deteriorate, and three months later he developed a 
spontaneous fracture. He was also found to have a hypercalciuria of such 
severity that the calcium precipitated on the sides of the urinal. In July of 
1925 an attempt was made to obtain improvement in his condition by means 
of a homologous transplantation of four parathyroid glands. This too failed 
to provide a cure. As a last resort, in 1925, ten years after Schlagenhaufer's 
proposal, Mandl performed the first parathyroidectomy. At exploration it 
did not take long to find a greatly enlarged parathyroid gland on the lower 
left side between the thyroid gland and the trachea. The tumor, which 
adhered to the recurrent laryngeal nerve, was removed. The other glands 
had a normal appearance. Six days after the operation, the diminishment 
of the hypercalciuria could be observed with the naked eye, and by the 
fourth post-operative month the bone anomalies were appreciably improved. 
Subjectively, too, there was an unmistakable recovery. In 1926 Mandl 
wrote a treatise in which he drew the conclusion that the success of the 
parathyroidectomy was probably based on the fact that the tumor indicated 
a hyperfunction of the gland. Unfortunately, six years later the patient 
developed a recurrence of the hyperparathyroidism, which seemed to offer 
support to those who had been critical of Mandl's view from the first. 
Mandl's act of desperation, which led to his patient's recovery, forms a 
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sharp contrast with the more biochemical approach to the clinical picture 
applied in the United States. After MacCallum and Voegtlin's discovery, 
the experimentation with hormone extracted from bovine parathyroid 
glands constituted a great advance. The best known are the experiments 
with extract prepared by Collip (1925), who showed that after excision of 
the parathyroid glands in dogs normocalcemia could be maintained by means 
of injections of parathyroid extract (PTE). Overdosage of PTE led to hyper-
calcemia. He also gave the first description of a hypercalcemic crisis 
induced by overdosage of parathyroid hormone. Greenwald and Gross 
(1926) found that after PTE injections hypercalciuria and hyperphospha-
turia developed to such a degree that it could only be due to bone destruction. 
Albright et al. (1929a,b) performed very exact balance studies on calcium 
and phosphate metabolism, and demonstrated that the first measurable 
reaction to PTE injections was an elevated phosphate excretion in the urine, 
from which they concluded that this reaction was a primary one. All 
further changes - such as hypophosphatemia, hypercalcemia, and hyper-
calcuria - were considered secondary to the elevated phosphate excretion. 
In the later widely known patient, Captain Charles Martell, who suffered 
from an extensive osteitis fibrosa with pathological fractures and urolithia-
sis, Hannon et al. (1930) found hypercalcemia, hypophosphatemia, and 
hypercalcuria. These findings led them to the correct conclusion that here 
there was a parallel between these biochemical changes and those found in 
experimental overdosage with parathyroid extract. They too nevertheless 
treated their patient initially with with PTE, which as could be expected 
resulted in increased complaints. Bauer et al. (1930), of the Massachusetts 
General Hospital in Boston, also examined this patient and confirmed the 
diagnosis. In addition to parathyroidectomy, they advised treatment with 
a phosphate-rich diet. Despite two negative explorations, they remained 
convinced of the correctness of their diagnosis. Due to the resoluteness of 
the patient and the conviction of his physicians, the tumor was finally found 
at the seventh exploration, lying in the anterior mediastinum next to the 
left innominate vein (Churchill & Cope 1934). 
When the physiological function of the parathyroid glands became 
known, interest in the histological picture of the tumors increased. Although 
several forms had been described, such as adenoma and hyperplasia (Guy 
1922), the findings continued to be highly confusing. Castleman and 
Mallory (1935) gave clearly defined criteria for the histological diagnosis of 
enlarged parathyroid glands. They distinguished adenoma, primary water-
clear cell hyperplasia, and the secondary hyperplasia due to a period of 
hypocalcemia. An important communication was the description of the 
4 
primary chief cell hyperplasia by Cope et al. in 1958. It was Cope in par-
ticular who was involved in parathyroid surgery from its beginning and who, 
in collaboration with the pathologist Castleman, initiated the development 
of a sound surgical treatment for this complicated disease. 
In Europe, Hellstrom has also done a great deal of this work in Sweden. 
His relatively somber view of the ultimate result of the operation, based on 
the fact that despite successful surgery many of his patients finally died of 
renal insufficiency, influenced general opinion in the period between 1945 
and 1960. In England, Dent contributed valuable methods for the diag-
nosis, and Davies obtained excellent surgical results. Together, they have 
been responsible for the first reliable insight into the etiology of tertiary 
hyperparathyroidism. 
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Chapter II - Anatomy and histology 
of the parathyroid glands 
§ 1. EMBRYOLOGY 
In mammals the parathyroids are derivates of the 3rd and 4th pharyngeal 
pouches (Boyd 1950, Schrier & Hamilton 1952, Dossel 1958). 
The lower parathyroid glands develop from the dorsal part of the entoderm 
of the 3rd pharyngeal pouches, the remaining part differentiating to become 
the thymus. During its descent, this pouch forms the ductus pharyngo-
brauchialis III, which later ruptures. The resulting tissue remants may 
develop into accessory thymic or parathyroid tissue. In this way, more 
than the normal number of parathyroid glands may develop. During the 
relative descent, the parathyroid tissue comes to lie apart from the thymic 
tissue. This separation is sometimes retarded, and in that case the lower 
parathyroids may come to lie not only in the thymus but also, in relation to 
the development of the heart, even lower (Hamilton et al. 1962). 
The upper parathyroid glands develop from the dorsal part of the entoderm 
of the 4th pharyngeal pouches. The ventral part attaches itself laterally to 
the thyroid gland which develops from the entoderm of the floor of the 
pharynx (Boyd 1950, Hamilton et al. 1962). This has two consequences: 
a. Due to this fusion the upper parathyroids undergo almost no descent, 
as a result of which they lie more cranially in the adult than those 
originating from the 3rd pharyngeal pouch. 
b. The contact of the upper parathyroids with the thyroid is closer than 
that of the lower ones. This results in less variation in the position of 
the upper parathyroids than is seen in the lower ones. 
Numerical variations 
Man normally has four parathyroid glands. Developmental anomalies can, 
however, give rise to a larger or smaller number (Y orris et al. 1962). The 
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inability to demonstrate more than three glands does not mean that four 
are not present (Heinbach 1933, Pyrteck & Painter 1964). For 428 autopsies, 
Gilmour (1938) found that in 0.2% of the cases only two glands could be 
located and in 6.1% three glands. He ascribed this mainly to having missed 
the glands. In addition, fusion of two glands or agenesis may be responsible 
for the presence of less than four glands (Black 1963). In 87% of his cases 
Gilmour found four parathyroid glands. A higher number of glands can 
cause failure in parathyroidectomy. In 6% of his series Gilmour found five 
and in 0.5% six parathyroid glands. Larger numbers, up to twelve 
(Erdheim 1904), have been reported. 
Our material confirmed these findings. In the 267 explorations, 939 glands 
were found, or an average of 3.5 per patient (see Table 1). 
Table I. Numbers of glands found in a series 
of 267 explorations 
0 glands in 3 patients ( 1.1%) 0 glands 
1 12 ( 4.5%) 12 
2 20 ( 7.5%) 40 
3 52 (19.4%) 156 
4 171 (64.0%) 684 
5 7 ( 2.6%) 35 
6 2 ( 0.8%) 12 
267 patients 939 glands 
The following remarks must be made in this connexion: 
a. In some patients one or more glands had been removed elsewhere in 
previous explorations. When we were aware of this, the glands were 
counted as found. 
b. In 15 patients a thyroidectomy had been performed before the para-
thyroid exploration and some parathyroids might have been inadver-
tently removed. In these 15 patients, 18 glands could not be located. 
c. In the earliest patients no systematic search was made for the other -
normal - glands after an 'adenoma' had been found. 
d. In 13 patients three glands were found on one side. 
A normal parathyroid gland weighs 30 to 35 mg. The lower pair is slightly 
heavier than the upper. The average weight is slightly higher in women than 
in men (Gilmour & Martin 1937). The dimensions of a gland are 3-6 X 2-4 X 
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0.5-2 mm, the length being the most variable. In adnlts the color of the 
glands is yellowish-brown. 
§ 2. THE POSITION OF THE GLANDS 
To locate the parathyroid glands during the operation, familiarity with 
their anatomical relation to the surrounding structures is of great impor-
tance because of the likelihood that the glands will be concealed in or behind 
fatty lobuli or in the connective tissue behind the thyroid gland. 
The upper parathyroid glands 
From the findings in Gilmour's series of 428 autopsies, the following distri-
bution can be calculated: 
Seen in the sagittal plane, the upper parathyroids lie in 
92% of the cases on the dorsal surface of the thyroid gland, 
6% of the cases between the thyroid gland and the esophagus, 
1.5% of the cases behind the pharynx or esophagus, and in 
0.5% of the cases between the thyroid gland and the carotid sheath or in 
the carotid sheath. 
Only once was a gland found on the anterior surface of the thyroid, but this 
may occur more frequently (Millzner 1927). The incidence of intrathyroidal-
ly located parathyroid glands is not sufficiently known. The glands often 
lie in a snlcus of the thyroid, but seldom really intrathyroidally, i.e. entirely 
surrounded by thyroid gland cells (Gilmour 1938, Pyrteck & Painter 1964). 
The upper parathyroid glands usually lie on the dorsal surface of the 
thyroid gland. If the latter is visualized as vertically divided into three 
parts, they are found: 
on the upper margin of the middle third in 
on the upper third in 
on the middle third in 
more dorsally, toward the esophagus in 
behind the esophagus in 
73.7% 
9.4% 
7.2% 
5.4% 
1.1% 
From the foregoing, it may be concluded that the upper parathyroids are 
usually found in close contact with the dorsal side of the thyroid, at the 
level of the cricoid cartilage. The more caudally they lie, the more dorsal 
their location. In extreme cases, especially with large tumors, they may 
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migrate toward the posterior mediastinum. The anatomical position of the 
upper parathyroid glands with respect to the inferior thyroid artery is less 
constant than that with respect to the recurrent laryngeal nerve, because 
the latter has a more constant position. The upper parathyroids lie dorsal 
to the artery and the nerve (Pyrteck & Painter 1964, Hunt et al. 1968). 
The lower parathyroid glands 
In 95% of the cases, the lower parathyroids lie within an area covering 2 em, 
cranially, caudally, or laterally, from the lower pole of the lateral lobe of the 
thyroid gland. The more caudal the location, the stronger the tendency to 
an intra thymic localization. In 9.1% of the cases the lower parathyroids 
lie between the trachea and the thyroid or on the trachea. The lower 
parathyroids lie ventrally with respect to the inferior thyroid artery and 
the recurrent laryngeal nerve (Gilmour 1938, Pyrteck & Painter 1964). 
In our material, of the 458 normal parathyroids 361 lay within and 97 
outside this region (78.8% and 21.2%, respectively). Of the 481 pathological 
glands, 343 had a normal location and 138 an abnormal (71.3% and 28.7%, 
respectively). Abnormal localization in tumors is ascribed in part to pressure 
from the surrounding tissue (swallowing), gravity, and suction due to the 
lower pressure in the thorax at inspiration (Cope 1966, Pyrah et al. 1966). 
There is no relationship between the position and the weight of the tumor 
or between the localization and the predominance of bone or kidney anoma-
lies (Lloyd 1968). But there seems to be a relationship between the size of 
the tumor and the plasma [Ca]. However, in a few patients with high plasma 
[Ca ], small tumors were found. 
The localization of normally situated parathyroid glands generally offers 
no difficulties if one takes the time for it. If they are not found, however, 
the possibility of an abnormal position must be considered. Abnormal 
localizations are notorious, 'the surgeon's ridclle' (Chiu-Ang Wang 1970). 
In principle, parathyroid gland tumors can be found in a region stretching 
from the base of the tongue to the diaphragm and from the clavicle to the 
vertebral column. 
The upper parathyroid glands, as already mentioned, are found in abnormal 
localizations more dorsally and( or caudally than usually. They must there-
fore be sought in the neck as well as near the trachea, between the trachea 
and the esophagus, para-esophageally, and between the esophagus and the 
spinal column. More caudally, they are to be found in the posterior medi-
astinum (seldom in the anterior mediastinum) (Cope 1960, 1966). Our 
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impression is that with large tumors of the upper parathyroids a more caudal 
position occurs more frequently than with smaller tumors. 
The lower parathyroid glands show no correlation between the size of the 
tumor and a more caudal position. We have obtained the impression that 
deep sinking of these tumors is rare, because with a mediastinal localization 
they usually lie firmly anchored in the thymus. Abnormal localizations are 
almost entirely confined to the anterior mediastinum. A mediastinal 
localization, whether of the upper or the lower parathyroids, is reported to 
occur in 0.5 to 21% of the patients (Norris 1947, Hellstrom & Ivemark 1962, 
Black 1963, Pyrah et al. 1966). This wide variation is probably due mainly 
to the fact that with a normal position of the head the tumor can lie retros-
ternally, whereas at hyperextension of the neck (as may occur during the 
operation) it is found in the neck. Tumors situated caudal to the aortic arch 
are rare. 
The mediastinally situated tumors of the lower parathyroids are often 
located in the thymus and in the thymic pedicle (Black 1963, Muller et al. 
1966). In Cope's series of 400 patients, 26 of the 84 mediastinally located 
tumors lay in the thymus (Nathanie!s et al. 1970). 
§3. VASCULARIZATION AND INNERVATION 
The arterial vascularization of the upper parathyroid glands is effected mainly 
by the inferior thyroid artery, which in 45% of the cases has a shunt with 
the superior thyroid artery (Halsted & Evans 1907, Mauro 1950). The 
upper parathyroids are supplied exclusively by the superior thyroid artery 
in 13% of the cases, the more frequently the higher the gland lies on the 
upper pole of the thyroid. In 25% they are supplied via an anastomosis 
between the superior and inferior thyroid arteries, particularly when the 
localization is juxta-cricoidal. In the remaining cases they are supplied by 
a terminal branch of the inferior thyroid artery. 
The lower parathyroids are ahnost always vascularized by a terminal 
branch of the inferior thyroid artery (Mauro 1950). The veins and lymphatic 
vessels enter the hilus together with the arteries, but the vessels may also 
penetrate the capsule and anastomose with the thyroid vessels (Balashev 
& Ignashkina 1964). 
Abnormally localized glands, e.g. on the pericardium, are sometimes 
supplied not by the inferior thyroid artery but rather from the immediate 
surroundings (Black 1952, Maurer et al. 1965). It is conceivable that this 
concerns a parathyroid that had migrated in an early embryonic stage. 
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Some surgeons attempt to locate an elusive gland by following the 
(dilatated) thyroid artery (State 1964, Hellner 1965, Pyrah et al. 1966, 
Goodman et al. 1969). In view of the variations in the vascularization, it 
must be kept in mind that this method can only be successful in some 
proportion of the cases. 
In our series of 267 patients we found the following arterial anomalies. 
The inferior thyroid artery was absent on the left in 15 and on the right in 
4 patients. In 2 cases there was a direct branch from the common carotid 
artery to the lower parathyroids. 
A bloodvessel serving as a guide to the tumor was mentioned in the 
surgical report 37 times in our material; its value for locating the tumor was 
difficult to determine. In 5 of these cases the tumor was found by dis-
secting along the course of the artery. The following case may serve as an 
example: 
During exploration in a 19 year old male, biopsy samples were taken from three 
normal parathyroid glands. the lower left gland was not found, and the operation 
was terminated. Post-operatively, hypercalcemia persisted. At re-exploration six 
weeks later, it was noticed that the left inferior thyroid artery was strongly displaced 
dovcnnvard, which made a retrosternal localization of a tumor seem possible. After 
sternotomy, a tumor which later proved to weigh 1500 mg was found just above the 
aorta, vascularized by a branch of the lowered inferior thyroid artery. 
The innervation of the parathyroids occurs from a perivascular plexus with 
two types of fibers: 
a. Large myelinized fibers running superficially in the tunica adventitia of 
the artery. This may concern a sensory type of fiber. 
b. Small unmyelinized fibers running deeper in the tunica media. These are 
orthosympathetic fibers without a distinct terminal structure and 
probably vasomotoric. However, they sometimes terminate in a knob-
like swelling on the cell membrane of the chief cell, which suggests an 
influence on secretion (Raybuck 1952). Objections have been raised by 
Zawistowzky (1965) to this finding. 
§ 4. HISTOLOGY OF THE PARATHYROID GLANDS 
The parathyroid glands are surrounded by a fragile capsule formed of 
collagenic, reticular, and elastic fibers. Vascularization occurs mainly from 
the hilus, from which the vessels radiate. The veins are large. In the 
perivascular connective tissue mast cells are present at all ages. Fatty tissue 
occurs increasingly with age up to the 50th year, the fat cells lying in the 
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perivascular tissue as well as solitarily or in groups distributed in the 
parenchyme. With increasing age the parathyroids undergo a certain degree 
of trabecularization, and septa develop as a result of the increasing amount 
of collagenous connective tissue. 
The parenchyme is composed of three main epithelial components with 
their transitional forms: 
a. Chief cells: Usually polygonal cells measuring 6 to 10 fL· The cytoplasm 
is slightly acidophilic and contains fine granules. The nucleus is dark. A 
distinction is made between light and dark chief cells according to their 
stainability with hematoxilin and eosine. 
b. Water-clear cells: These round cells are twice as large as the chief cells. 
The nucleus has approximately the same appearance as that of the chief 
cell. The cytoplasm is clear, due either to total vacuolization (Castleman 
1952, Engfield et al. 1959, Holzman & Lange 1963) or to artefaction (Gilmour 
1939, Stoeckel & Porte 1966). As transitional type between the chief cell 
and the water-clear cell, the transitional water-clear cell, is mentioned. 
c. Oxyphil cell: Also called the acidophil cell. The size of these cells varies. 
The nucleus is hyperchromatic, the cytoplasm contains oxyphilic granules 
and vacuoles. Here again, a distinction is made between light and dark 
cells. 
So far, it has not been possible to determine the relative importance and 
function of these various types of cell. There is no con census concerning the 
amount of PTH secretion by the various types of cell. There are indications 
that transition from one type into another is possible (Raisz 1963, Botta 
1965, Roth & Raisz 1966, Weymouth & Sheridan 1966, Christie 1967, 
J owsey & Raisz 1968). 
The architecture of the parenchyme is highly dependent on age and the 
activity of the gland. The same holds for the cellular composition of the 
population of the parenchyme (Gilmour 1937/1939, Castleman 1952, Eder 
1961a,b, Christie 1967). 
In healthy adults, the microscopical picture varies widely within a single 
gland. The chief cells may form compact nodular groups separated by septa, 
coarse trabeculae, lobuli, and large, sometimes ramified, acini. Nodules of 
oxyphil cells occur in the normal gland, but these cells are also found lying 
disseminated in the parenchyme. Solitary fat cells and interstitial ac-
cumulations of fat are present. An equally constant finding is microscopi-
cally visible cysts. Encountered less often in normal parathyroids are 
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alveoli of cylindrical epithelium, pseudo-alveoli, and vesicles filled with 
pseudo-colloid (Gilmour 1939). In such cases there is a considerable chance 
that investigation of frozen sections of biopsy material will lead to the 
erroneous diagnosis thyroid tissue, as occurred in one of our patients. 
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Chapter III - Some remarks 
on the physiology of the parathyroid 
hormone and calcitonin 
Parathyroid hormone influences the calcium metabolism of the bone, 
phosphate and calcium clearance in the kidneys, and calcium resorption in 
the gut, The calcium homeostasis in the blood is maintained primarily by 
the feedback effect of the plasma [Ca] on the PTH secretion. There is no 
similar mechanism for the regulation of the phosphate homeostasis, since 
PTH secretion is not directly influenced by the plasma [PO,] (Potts 1968, 
Roth et al. 1968). The application of radioimmunoassay techniques has 
made it possible to measure plasma [PTH] (Berson et al. 1963, Berson & 
Yalow 1967, Lequin 1969, Arnaud et al. 1970). Unfortunately, this deter-
mination is still extremely difficult to perform and cannot yet be considered 
consistently accurate, although it supplied the ultimate proof that PTH 
secretion is activated only by hypocalcemia. The role played by hypo-
magnesemia is not yet entirely clear. There seems to be a linear inverse 
relationship between plasma [Ca] and plasma [PTI-1]. The half-life of the 
hormone in vivo is about 20 minutes. At a normal rate of secretion, the 
parathyroid glands must renew their PTH content completely 3 to 15 times 
per hour by de novo synthesis (Potts et al. 1968). 
PTH has a direct effect on bone, resulting in the release of calcium and 
phosphate ions into the blood (Thompson & Pugsley 1932, Collip et al. 1934, 
Barnicot 1948). The biochemical background of this phenomenon is not yet 
completely understood (Gaillard 1968, Hekkelman 1968, Nichols 1970). 
In the kidney, PTH reduces the tubular resorption of phosphate. This 
effect occurs very rapidly after the administration of PTH, in contrast to 
the effect of PTH on the bone and the subsequent rise of the plasma [Ca] 
(Greenwald & Gross 1926, Albright et al. 1929•·", Chambers et al. 1956, 
Kyle et al. 1958, Bijvoet & van der Sluys Veer 1968). PTH also induces an 
increase of the tubular resorption of calcium. But despite this elevated 
tubular resorption, as a rule a patient with hyperparathyroidism and a 
normal or only slightly disturbed kidney function will show hypercalcuria, 
because the tubular calcium resorption cannot keep pace with increased 
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calcium concentration in the ultrafiltrate (Talmage & Krainz 1954, Kleeman 
et al. 1958, Transb0l et al. 1968). 
In the intestine PTH causes an increase of the calcium absorption (Ras-
mussen 1953, Talmage & Elliot 1958, Lafferty & Pearson 1963). The 
absorption of phosphate from the gut is also elevated (Borle et al. 1963). 
For the regulation of the plasma [Ca], however, these effects are of less 
importance. 
Experiments with perfusion of the thyroid and parathyroid glands enabled 
Copp et al. (1962) to demonstrate the presence of a factor lowering the 
calcium level, which they called calcitonin (CT). For a proper understanding 
of the development of hypercalcemia in hyperparathyroidism, more must 
be known about the role played by calcitonin. Little is known, however, 
concerning the countereffect of calcitonin in hyperparathyroidism and its 
role in the pathogenesis of the hyperparathyroidism. 
Calcitonin and the C-cells 
Copp (1962) and Hirsch et al. (1963) have shown that the thyroid gland may 
be the source of calcitonin. Raymond (1932) and Nonidez (1932/1935) had 
previously described a certain type of cell in the thyroid gland; at the time 
this cell was called parafollicular, and after the discovery of calcitonin, the 
C-cell. Further research showed that these parafollicular cells undergo 
histochemical changes under the influence of hypercalcemia, which meant 
that they might be the source of calcitonin (Foster et al. 1964, Pearse 1966). 
This was confirmed by Bussolati and Pearse in 1967 by means of immuno-
fluorescence studies. In the lower vertebrates the C-cells are situated in the 
ultimobranchial bodies (Copp et al. 1967, Tauber 1967). In man the C-cells 
probably derive from the ventral side of the 4th pharyngeal pouch. The 
latter attaches itself laterally to the thyroid gland developing from the floor 
of the mouth and is then incorporated into it. In the human adult they lie 
mainly dorsomedially in the lobes of the thyroid gland (Pearse & Carcalheira 
1967, Solcia 1969). But the C-cells can also be found extrathyroidally and 
even in the parathyroid glands (Galante et al. 1967). This might explain the 
fact that after a total thyroidectomy a normal CT level is sometimes found 
(Gudmundsson et al. 1966). The parathyroidal localization of calcitonin-
secreting cells may possibly explain the slight initial decrease of plasma 
[Ca J sometimes seen as an effect of the administration of parathyroid ex-
tract, which has also been ascribed to the existence of aCT 'releasing factor' 
in the parathyroid gland (Haas 1964, Gittes & Irvin 1965, Foster 1966, 
Gittes & Radde 1966). 
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In all likelihood, calcitonin occurs earlier in the evolutionary process than 
parathyroid hormone. Ultimo branchial bodies are also found in cartilaginous 
fish, which of course have no calcium-containing skeleton (Copp. et al. 1967, 
Talmage 1967, Tauber 1967). 
That hypercalcemia constitutes a stimulus for the secretion of calcitonin 
has recently been conclusively demonstrated by Arnaud et al. (1970). 
The CT secretion stops when the plasma [Ca J drops to 0.5 mgjlOO ml 
below the physiological lower limit. Copp (1968) showed a linear 
relationship between the plasma [Ca] and the plasma [CT]. The half-life 
of calcitonin in vivo is estimated at 4 to 12 minutes (Potts 1967). 
In a brief and especially in a sudden hypercalcemia, the CT feedback 
mechanism seems to be very important (Toverud 1966, Copp 1968, Foster 
1968). CT lowers the plasma [Ca] by inhibiting bone resorption. The effect 
of CT is dependent on the rate of bone formation, i.e. in mature bone the 
effect is not always demonstrable. It can be demonstrated in young bone 
or in bone where resorption has been stimulated by PTH or vitamin A and 
in bone of patients with Paget's disease (lVIilhaud et al. 1967, Bijvoet et al. 
1968, Foster 1968). 
On the kidney, calcitonin has a phosphaturic effect (Robinson et al. 1966, 
Morii & Deluca 1967). In some patients with Paget's disease or osteoporosis, 
a rapidly appearing calcuric effect can be demonstrated (Bijvoet et al. 1970). 
It is not yet clear whether this is a direct effect or secondary to an increase 
in the PTH secretion resulting from the hypocalcemia (Bijvoet et al. 1968, 
Levin & Bell1968, Bordier 1969, Pak 1969). The effect of calcitonin on the 
renal calcium excretion is still controversial. In some patients with Paget's 
disease or osteoporosis, a rapidly appearing calcuric effect has been demon-
strated (Bijvoet et al. 1970). 
16 
Chapter IV - Histology of the 
parathyroid tumors 
After the discovery of the primary chief cell hyperplasia (Cope et al. 1958), 
in which in principle all the parathyroids are affected, the differential 
morphological diagnosis between the nodular form of primary chief cell 
hyperplasia and adenomata proved to be extremely difficult. Currently, the 
diagnosis primary hyperplasia is made with increasing frequency (Cope 
1966). The diagnosis of water-clear cell hyperplasia is generally not difficult 
(Black & Utley 1968). 
The series reported by Woolner et al. (1958), Cope et al. (1958), Roth 
(1962, his series), and Hellstrom and Ivemark (1962), comprise 620 cases 
showing the following distribution: 
Single adenoma 
Multiple adenomata 
Primary chief cell hyperplasia 
Primary water-clear cell hyperplasia 
620 patients 
(%) 
83.0 
3.7 
4.4 
6.9 
343 patients (Cope 1966) 
(%) 
77.0 
3.8 
10.8 
4.4 
Parathyroid carcinoma is the cause of pnmary hyperparathyroidism in 
0.5 to 2% of the cases. 
Cope's 1966 series comprises 343 cases, including his 1958 material. The 
distribution of the diagnoses of the 143 cases added from the material 
collected between 1958 and 1966 (obtained by subtraction) is: 
Single adenoma 
Multiple adenomata 
Primary chief cell hyperplasia 
Primary water-clear cell hyperplasia 
143 patients 
17 
(%) 
78.0 
2.0 
19.0 
< 1.0 
138 patients (Lloyd 1968) 
(%) 
86.0 
0.1 
10.7 
(<0.1) 
The most recent series is that of Lloyd (1968). From comparison of all 
these values it is evident that: 
a. the diagnosis multiple adenomata is now made less frequently; 
b. the diagnosis primary chief cell hyperplasia is made with increasing 
frequency (25% of Cope's later cases in 1966). Strauss and Paloyan 
(1969) even found a form of primary hyperplasia in 58% of their cases; 
c. the diagnosis primary water-clear cell hyperplasia is rarely made any 
longer. 
These differences could possibly be due to changes in the histological criteria 
applied for a given disease and in the morphological picture seen at earlier 
diagnosis. Both these factors are probably involved. 
§ 1. SINGLE ADENOMA 
Adenomata vary in weight between 100 mg and 60 g. 
Macroscopically, the color of the adenoma is often an orange-brown but 
may vary from yellow to black. The surface is usually smooth and sometimes 
slightly lobular. Occasionally, calcification occurs in the capsule (Castleman 
1952). In principle, there is no adhesion of the gland to surrounding tissue 
except in cases in which an operation has previously been performed in the 
region (Roth 1962). 
Microscopically, the gland shows a sharply defined mass of adenomatous 
cells surrounded, in the ideal section, by a rim of 'normal tissue'. The 
adenoma tissue is usually composed of lightly stained chief cells or a mixture 
of chief, oxyphil, transitional water-clear, and water-clear cells. Classifi-
cation of the adenoma is dependent on the criteria applied by the pathologist 
(Woolner et al. 1952, Rienhoff et al. 1968, Lloyd 1968). There seems to be no 
correlation between the dominant cell type and the clinical picture (Castle-
man 1952, Lloyd 1968). 
§ 2. MULTIPLE ADENOMATA 
There is no difference between the histological pictures of single and multiple 
adenomata (Roth 1962). The diagnosis double adenomata has been made 
with decreasing frequency since the discovery of primary chief cell hyper-
plasia and improved understanding of the distinction between these two 
pictures. Triple adenomata are exceedingly rare (Norris 1947). Adenoma 
formation in all four of the glands has only been reported once (Rubens et al. 
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1969), but this has been criticized on fundamental grounds (Paloyan & 
Reiss 1969). 
§ 3. PRIMARY HYPERPLASIA 
Primary water-clear cell hyperplasia: This diagnosis too tends to be made 
less frequently. Macroscopically, the glands are highly irregular in shape 
and show 'pseudopodia!' protrusions. The color is chocolate-brown. All 
the glands are always affected, but the upper pair usually shows greater 
enlargement than the lower pair. Microscopically, the gland is composed 
of large water-clear cells. The picture may strongly resemble that of renal 
cell carcinoma (Castleman 1952, Woolner et al. 1952, Roth 1962). 
Primary chief-cell hyperplasia: In the most typical case all the parathyroids 
are enlarged. The combined weight can amount to 25 g. The glands have 
an irregular shape but seldom show pseudopodia! protrusions macroscopi-
cally. The color is the same as is seen in adenoma. Microscopically, the 
gland consists of diffuse hyperplastic tissue composed of chief cells among 
which pale oxyphil and water-clear cells occur individually or in aggregation. 
A peripheral border of normal tissue cannot be demonstrated in the ideal 
case. 
Secondary hyperplasia may be histologically impossible to distinguish 
from primary chief cell hyperplasia. Macroscopically, the gland is reported 
to have a more creamy-gray color in secondary hyperplasia (Castleman 
1952, Cope et al. 1958, Roth 1962). 
§ 4. NODULAR HYPERPLASIA 
Nodular hyperplasia occurs more frequently than diffuse hyperplasia. The 
picture is characterized by one or more nodules surrounded by compact 
hyperplastic tissue (Graber & Jacobs 1968, Rienhoff et al. 1968), and is less 
uniform than that of chief cell hyperplasia. The term microadenoma is also 
used (Eder 1961a). The nodular character is increased by the presence of 
stroma (Roth 1962). Nodular hyperplasia is often found in multiple endo-
crine adenomatosis (Woolner et al. 1952) and familial hyperparathyroidism 
(Graber & Jacobs 1968). 
When the histological picture is less pronounced, the differentiation with 
respect to the so-called functional (i.e. secondary) focal hyperplasia is very 
difficult (Eder 1961a). When the glands show distinct pathological changes, 
differentiation with respect to multiple adenomata is often impossible 
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(Block et al. 1967). Nodular hyperplasia probably represents a transitional 
form between diffuse chief cell hyperplasia and parathyroid adenoma 
(Black & Utley 1968, Straus and Paloyan 1969). 
Consequently, the clear-cut picture described for primary chief cell hyper-
plasia is far from universal. As a result, attempts have been made to establish 
clearly defined criteria for the differential diagnosis between chief celladenoma 
and primary chief cell hyperplasia. Some authors state that the presence of a 
rim of normal tissue on the' capsule' of the neoplasm is characteristic of adeno-
ma (Castleman 1952, Woolner et al.1952, Roth 1962, Blocketal.1967), but this 
rim is absent in an appreciable proportion of the cases or sections (Cope et al. 
1958, Lloyd 1968). Because of the formation of connective tissue occurring 
at more advanced ages, a hyperplastic gland may show a virtual rim of 
'normal' tissue (Utley & Black 1967, Black & Utley 1968, Rienhoff et al. 
1968). Therefore, the presence or absence of this normal rim around a tumor 
is not a reliable criterion for the differential diagnosis between primary 
chief cell hyperplasia and adenoma. Other characteristics, such as a decrease 
of the quantity of fatty tissue normal for a given age (Woolner et al. 1952), 
the structure of the gland, and the presence of polynuclear cells (Castleman 
1952), are not conclusive for the diagnosis either, because these criteria 
too have only relative validity. 
Since according to the original description given by Cope et al. (1958) all 
the glands are enlarged in primary chief cell hyperplasia, the presence of a 
normal gland is held to be the only remaining criterion for the diagnosis 
adenoma(ta) (Hellstrom & Ivemark 1962, Roth 1962, Black & Utley 1968, 
Lloyd 1968). Unfortunately, this too has given rise to objections (Block 
et al. 1967, Straus & Paloyan 1969). Because a gland can be macroscopically 
normal but histologically hyperplastic, those who still maintain this 'abso-
lute' criterion would nevertheless have to investigate biopsy samples of 
apparently normal glands to demonstrate adenoma in another gland 
(Bradshaw et al. 1964, Adams et al. 1965, Block et al. 1967, Black & Utley 
1968). 
Because the histological picture of material prepared by frozen-sectioning 
may be difficult to evaluate, a conclusion on the above-mentioned grounds 
(no matter what the value attached to them) cannot be made until paraffin 
sections have been studied. In addition, the only diagnostically reliable 
material is provided by sections through the hilus, which of course can only 
be done in excized glands. Even then, the difference between a normal and 
a slightly hyperplastic gland may be very difficult to distinguish. Con-
comittant renal insufficiency confuses the picture even more, due to the 
possible secondary hyperplasia (Golden et al. 1965). These problems compli-
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eating the interpretation of the histological picture led Pyrah et al. (1966) 
to state that 'Under the heading of multiple adenoma there seems to remain 
an uneasy limbo containing the true multiple adenomata and the diffuse 
chief cell hyperplasia'. 
Particularly when not all the glands can be located and when enlargement 
of glands is dubious, a definitive diagnosis is not possible. More certainty 
as to the nature of the tumors can only be reached after a prolonged 
follow-up period: the curative effect of total removal of multiple adenomata 
is permanent, but incomplete removal in primary hyperplasia could be 
followed by a recurrence after an interval of normocalcemia. Per-operative 
prediction in this respect is in any case impossible (Hellstrom & I vemark 
1962, Bradshaw 1966, Utley & Black 1967, Black & Utley 1968, Graber & 
Jacobs 1968, Rienhoff et al. 1968, Straus & Paloyan 1969). 
In our series the pathologist had exactly the same experience as described 
in the foregoing. In the first fifty patients (1950-1962) the diagnosis was 
almost exclusively adenoma or adenomata. After primary chief cell hyper-
plasia became known, this diagnosis was made with increasing frequency 
until finally mainly hyperplasia and nodular hyperplasia were found, even 
when only a single gland was macroscopically enlarged. At re-evaluation 
of the sections from the 1950-1962 period, hyperplasia was found in most 
cases. 
To solve this problem, a comparative study was performed in normal 
parathyroid glands obtained at autopsy. The results showed that patho-
logically enlarged glands sometimes present a completely normal picture. 
Therefore, the differentiation between nodular hyperplasia and adenomata 
had to be considered unreliable. After arriving at this conclusion, we stopped 
recording the histological diagnosis and no longer took it into consideration 
with respect to treatment. The entire problem has been succinctly stated 
by the pathologist R. 0. van der Heul: 'The best histological criterion is the 
weight of the gland'. 
Nevertheless, the pathologist's opinion is indispensable for the surgeon. 
Only he can provide certainty about the nature of the biopsy material. For 
every structure resembling parathyroid tissue, a biopsy sample must be 
taken so that he can answer the question: Is this parathyroid? Confusion 
with lymph glands, aberrant thyroid gland tissue, and especially aberrant 
thymus tissue can lead to the failure of an operation. Only in two of 
our cases did this method prove inadequate: in one, a colloidal nodule of the 
thyroid gland was taken for parathyroid tissue and in the other, parathyroid 
tissue was not recognized. In both cases the true nature of the tissue was 
identified in the paraffin sections. 
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The difficulties sometimes associated with the differentiation between 
thyroid and parathyroid tissue are also known from the literature (Hell-
strom & lvemark 1962, Howell1965). 
It need hardly be said that this problem can strongly influence the course 
and results of the exploration. 
§ 5. CARCINOMA 
The parathyroid carcinoma showing endocrine activity is rather rare, 
comprising 0.5 to 2% of the parathyroid tumors. The tumor is usually 
larger than that of an adenoma and is palpable in the neck in at least 50% 
of the cases. 
The clinical picture is characterized by the sudden onset of the complaints 
and a high plasma [Ca] (averaging 15 mg/100 ml) (Castleman 1952, Holmes 
et al. 1969). At operation, a striking feature is that the tumor is usually 
adherent to the surrounding tissues, in contrast to the situation in adenoma 
and primary hyperplasia. The tumor often has a grayish-white color and 
is highly irregular in shape. The cut surface is usually light to dark brown. 
These findings should alert the surgeon to the possibility of malignancy, 
since the frozen sections often do not provide conclusive information on this 
point. Tumoral growth is slow, and metastasis occurs preferentially in the 
lymphatic system. The clinical course is characterized by numerous re-
operations because of cervical recurrences (Holmes et al. 1969). The micro-
scopic picture and the clinical course are frequently divergent: mitotic 
figures, nuclear hyperchromasia, bizarre nuclei, and giant cells are described 
for benign parathyroid tumors, and metastases of parathyroid tumors 
showing no mitotic figures have also been reported (Woolner et al. 1952, 
Holmes et al. 1969). Therefore, only invasive growth into surrounding tissue 
(esophagus, trachea, neck muscles, recurrent laryngeal nerve) and metas-
tasis are generally accepted as absolute criteria for carcinoma of the para-
thyroids (Woolner et al. 1952, Roth 1962, Lloyd 1968, Holmes et al. 1969, 
Kelly 1969). 
Our material does not include even a single case of parathyroid carcinoma. 
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§1. 
Chapter V - Pathogenesis of 
primary hyperparathyroidism 
According to the literature, a solitary adenoma is found in primary hyper-
parathyroidism in at most 80% of the cases, and more than one gland is 
involved in at least 20% (usually nodular chief cell hyperplasia). In our 
material more than one gland was affected in almost 45% of the cases. 
For the discussion of the pathogenesis of primary hyperparathyroidism, 
the distinction according to the involvement of one and more than one gland 
or on the basis of solitary adenoma and primary hyperplasia, can be applied. 
Solitary adenoma can be seen as a local cellular derailment within a single 
parathyroid gland (to be left out of consideration here) and the hyperplasia 
resulting from a constant or intermittent stimulation of all the parathyroids 
(Castelman & Mallory 1935). In view of the extremely small chance that a 
local derailment will occur in more than one of the parathyroids simul-
taneously, we are of the opinion that it is justifiable to call any case of 
primary hyperparathyroidism in which more than one gland is affected a 
form of primary hyperplasia. 
Up to the present day, only one route has been demonstrated for the 
simultaneous stimulation of all the parathyroid glands, and that is hypo-
calcemia. How this hypocalcemia originates and subsequently gives rise to 
hypercalcemic hyperparathyroidism with its pathological substrate, will 
be discussed in this chapter. 
Chronic stimulation of the parathyroid glands and incapacity for re-involution: 
Prolonged hypocalcemia due to inadequate calcium resorption from the gut, 
an excessively high calcium excretion in the urine, and a reduced sensitivity 
to vitamin D in renal insufficiency, can given rise to a physiological para-
thyroid hyperplasia, i.e. 'secondary hyperparathyroidism. Whether or not 
the cause of this calcium loss persists, an autonomous hyperparathyroidism 
can develop (Davies et al. 1956, 1968, Dent 1962, McPaul et al. 1964, Wilson 
et al. 1964, Mcintosh et al. 1966, Lameyer et al. 1967, Fisher et al. 1968, 1969, 
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Jeremy 1968). St. Goar called this tertiary hyperparathyroidism (Castleman 
& Kibbee 1963). In this affection, adenoma formation in one or more glands 
is seen in some of the patients. In primary as well as in tertiary hyperpara-
thyroidism, hyperplastic glandular tissue showing only hyperplastic changes 
can show autonomous behavior. In spite of the hypercalcemia, the PTH 
secretion is too high and after some time (months) shows no tendency to 
decrease, even after calcium infusion. In secondary hyperparathyroidism, 
the PTH level does fall after calcium infusion (Berson & Y alow 1966). 
The experiments of Gittes and Radde (1966) have shown that an erroneous 
evaluation of the histological substrate is not involved here: multiple 
isologous parathyroid transplantations in inbred rats resulted in a distinct 
hyperparathyroidism. After 24 days there was still no tendency for hyper-
calcemia to diminish. This hyperparathyroidism is probably to be attributed 
to an excess of normal parathyroid tissue whose function and quantity are 
not reduced by hypercalcemia. This assumption is supported by the fact 
that neither in hypercalcemia due to bone metastases nor in pseudo-
hyperparathyroidism can involution of the parathyroid glands be demon-
strated (Svane 1964, Horeau et al. 1965, Seftel & Gusberg 1965, Kohout 
et al. 1966, Sherwood et al. 1967). Basal functioning of the parathyroids in 
hypercalcemia has been demonstrated (Schmidt et al. 1966). In hyper-
calcemia the cell itself shows only a reduction in the amount of cytoplasm 
(Raisz 1963). Adequately sensitive methods to measure PTH are not yet 
available to make it possible to prove that in hypercalcemia a basal PTH 
excretion persists. The genesis of hyperparathyroidism can be understood 
better on the basis of the following hypothesis: hypocalcemia gives rise to 
hypertrophy of the parathyroid cells and to hyperplasia (i.e. an increase of 
the amount of normal parathyroid gland tissue), as a result of which an 
increased basal PTH secretion develops, which in turn gives rise to the 
clinical picture of hyperparathyroidism. This hypothesis is in agreement 
with the statistical finding that the plasma [Ca J is higher the higher the 
weight of the tumor (Hodkinson 1963, Lloyd 1968). It is not excluded, 
however, that over a longer period (months) a re-involution of the para-
thyroid glands may occur (Alfrey et al. 1968, J owsey & Raisz 1968). 
Thus, chronic hypocalcemia can be the cause of (tertiary) hyperpara-
thyroidism. It is not clear what percentage of the cases we call primary 
hyperparathyroidism are actually tertiary, either because there has been an 
unrecognized period of external inducement of hypocalcemia, e.g. by vitamin 
D deficiency (Dent 1962), or some unknown factor or factors. In many 
cases of primary hyperparathyroidism there is a concomittant disease whose 
relationship with the hyperparathyroidism is obscure (Davies et al. 1968). 
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Primary hyperparathyroidism occurs about twice as often in women as 
in men. No causal relationship with gravidity and lactation can be demon-
strated (Hellstrom & Ivemark 1962). In children there is no predilection 
for either sex (Miihlethaler et al. 1967); this is confirmed up to the age of 45 
by our material. These findings make it interesting to consider the role that 
other hormones involved in calcium metabolism could play in the patho-
genesis of primary hyperparathyroidism. 
§ 2. HYPERPARATHYROIDISM AND OTHER HORMONAL FUNCTIONS 
Calcitonin 
In short-lasting hypercalcemia, the CT feedback mechanism is of great 
importance (Toverud 1966, Copp 1968, Arnaud et al. 1970). In chronic 
hypercalcemia, whatever the cause, the functioning of this system is ap-
parently so disturbed that redressment to normocalcemia by CT is no longer 
possible. There are two possible reasons for this: 
a. The CT production is adequate but the site of its effect is less sensitive 
for the hormone. This is in contradiction with the reported effect of CT 
on active bone as expected in hyperparathyroidism (seep. 16). 
b. The CT production is inadequate: in chronic hypercalcemia the C-cells 
do not produce sufficient CT to compensate for the primary disorder. 
The CT level in the thyroid gland in primary hyperparathyroidism does 
not provide conclusive information about this (Tashjian & Voelkel1968). 
Focal and diffuse C-cel hyperplasia have been demonstrated in hyperpara-
thyroidism (Kuhlencord & Kracht 1968, Kracht & Hachmeister 1969, 
Young 1969). In three patients with hyperparathyroidism, an elevated 
plasma [CT] level was found twice (Gudmundsson et al. 1969). After 
injections of calcitonin, the hypercalcemia of hyperparathyroidism 
decreases. 
This points to a deficiency in the endogenous CT production under these 
conditions. Gittes demonstrated in a very elegant series of experiments 
that this probably depends in part on the quantity and not solely on the 
quality of the C-cells. An increase of plasma [CT] in experimental hyper-
parathyroidism in the rat leads not only to a reduction of the hypercalcemia 
but also to a decrease of plasma [PO 4] and calcium excretion. At the same 
time, far fewer bladder stones are formed (Gittes & Radde 1966, Gittes 
& Wells 1967). The long-term clinical course in a patient with primary 
hyperparathyroidism kept normocalcemic by CT injections remains an open 
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question. Insufficient research has also been done on the influence exerted 
by the endogenous CT production in hyperparathyroidism on the changes 
in bone and kidney. 
H ypercatcitoninemia 
The coincidental occurrence of CT-producing medullary thyroid gland 
carcinoma and parathyroid gland tumors, pheochromocytoma, and possibly 
neurofibromatosis has been reported (Sipple 1961, Sarosi & Doe 1968), but 
this can only be seen as a sporadic cause of (secondary) hyperparathyroidism, 
because C-cell carcinomas are rare (Williams et al. 1966, Melvin & Tashjian 
1968, Heimann et al. 1970). In one of our patients, too, a medullary thyroid 
carcinoma was removed during a successful parathyroidectomy. In her 
sister (not included in the present series) a medullary thyroid gland carci-
noma was also resected many years later, marked enlargement of one of the 
parathyroids being observed at operation. 
Thyroxin 
This hormone increases calcium turn-over of the bone. Hyperthyroidism 
can be accompanied by hypercalcemia and osteoporosis, and hypocalcemia 
can develop in hypothyroidism. Hyperparathyroidism is often accompanied 
by disorders of the thyroid gland (non-toxic goiter, thyroid gland carcinoma, 
adenoma, or thyrotoxicosis) in as much as 40% of the cases (Hellstrom & 
lvemark 1962, Adams & Murphy 1963, Werdelin 1964, Block et al. 1967, 
Davies et al. 1968, Heimann et al. 1970b). Here there is perhaps no question 
of a thyroid gland disease found accidentally during parathyroidectomy 
(Laing 1969), but the pathogenetic relationship is obscure. A possible 
explanation would be a stimulation of the parathyroids due to hypocalcemia 
in (transient?) hypothyroidism. Besides the medullary thyroid gland 
carcinoma, we found thyroid anomalies in 51 patients (20%) with demon-
strated hyperparathyroidism. In 43 of these patients a nodular dysplastic 
goiter with euthyroidism was found. In 3, Hashimoto's disease was demon-
strated and in 2 hypothyroidism with certainty, one of the latter on the 
basis of thyroid gland aplasia. Theoretically, in these patients the 
occurrence of parathyroid gland stimulation due to diminished sensitivity 
of the bone for PTH in hypothyroidism cannot be excluded. Two patients 
also had hyperthyroidism; this combination is also known from the literature 
(Bortz et al. 1961, Breuer et al. 1966). In one patient in our series a thyroi-
dectomy was later performed for papillary carcinoma (see Table II). 
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Table II. Thyroid gland anomalies in 52 patients with primary 
hyperparathyroidism 
Nodular goiter (dysplastic) 
Hashimoto's disease 
Hyperthyroidism 
Hypothyroidism 
Thyro-aplasia 
Papillary carcinoma 
Medullary carcinoma 
Total 
Corticosteroids 
No. of patients 
43 
3 
2 
1 
1 
1 
1 
52 
Corticosteroids also influence calcium metabolism. In Addison's disease 
hypercalcemia may be present, in hypercorticism an osteoporosis, usually 
with nonnocalcemia. Corticosteroids have an antagonistic effect on the 
effect of PTH, but how this operates is not known (Robinson & Walser 1964, 
Eliel 1965, Wajchenbach et al. 1965, Jowsey & Simons 1968). It was 
recently found that calcitonin production is possibly inhibited by corti-
costeroids (Azzali 1969, Gozarin 1969). It is conceivable that there is a 
calcitonin-like factor in the adrenal gland (Kaplan 1969). In Cushing's 
disease a pathogenetic relationship with primary hyperparathyroidism has 
been suspected but never demonstrated. The coincidence of these two 
clinical pictures occurs only in multiple endocrine adenomatosis. Cushing's 
disease and iatrogenic overdosage of corticosteroid can coincide with 
osteoporosis, but a significant relationship with hyperparathyroidism has 
not been demonstrated. This combination did not occur in our material. 
Growth hormone 
Acromegaly may be accompanied by hypercalcemia and hypercalcuria. 
The combination with hyperparathyroidism, generally caused by chief cell 
hyperplasia, is known (Hubner 1967). This usually concerns a form of 
multiple endocrine adenomatosis in which a colloidal goiter is not in-
frequently found (Hartog et al. 1967). Some authors think that the cause 
lies in a genetic error (Vancil & Locke 1965). Summers et al. (1966) believe, 
to the contrary, that the parathyroid hyperplasia is secondary to the 
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acromegaly, because in their case the hypercalcemia disappeared after 
treatment of the hypophyseal tumor. 
A possibly unrecognized factor in the pathogenesis might be constituted 
by an as yet undemonstrated parathyroid-stimulating hormone. In our 
material there are two cases of acromegaly with hyperparathyroidism. 
Jvhtltiple endocrine adenornatosis and familial hyperparathyroidism 
In multiple endocrine adenomatosis various combinations of parathyroid, 
Langerhans' cell, hypophysial, thyroid, and adrenal hyperplasia, as well as 
adenomas, occur in a single syndrome. The clinical picture consists of the 
coincidental occurrence of hyperparathyroidism, the Zollinger-Ellison syn-
drome, insulinoma, acromegaly, hyperthyroidism, and Cushing's disease, 
in all possible combinations (Wermer 1954, 1965). It is often difficult if not 
impossible to explain the simultaneous occurrence of one or more of these 
diseases, sometimes themselves causing hypercalcemia, in combination 
with hyperparathyroidism, on the basis of chronic hypocalcemia. 
Multiple endocrine adenomatosis often occurs familially (Wenner 1954, 
1963, Ellison & Wilson 1964-, Dutta et al. 1968, Renwick et al.1968). Familial 
hyperparathyroidism without other endocrinopathy has often been described 
(Adams et al. 1965, Graber & Jacobs 1968). In this affection, as in multiple 
endocrine adenomatosis, all the parathyroids are usually enlarged (Cope et 
al. 1958). It is possible that both are autosomal dominant hereditary 
diseases with an anomaly in the same gene (Cutler et a!. 1964, Schachter et 
al. 1966). 
There are two possible explanations for these patterns; a hereditary defect 
in the mechanism regulating cell growth in the above-mentioned organs or a 
defect in the feedback mechanism controlling the hormone production and 
therefore affecting these organs. 
This again raises the question of whether, in addition to hypocalcemia, a 
parathyroid-stimulating factor (hormone?) exists. This hypothetical hor-
mone could explain the occurrence of hypercalcemia in parathyroid hyper-
plasia, as seen in multiple endocrine adenomatosis. 
A possible relationship between the excretion of PTH and that of thyroxin, 
corticosteroids, and growth hormone has already been discussed, which 
leaves the influence of the pancreas on calcium metabolism to be treated. 
The pancreas and hyperparathyroidism 
Hypocalcemia as a complication in acute pancreatitis rs a well-known 
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phenomenon and is ascribed to saponification of calcium ions. This is not 
the only cause, however, In acute and intermittent pancreatitis an elevated 
plasma glucagon level is found, and hyperglucagonemia can lead to hypo-
calcemia (Paloyan et al. 1967•, b). How this effect is induced is not clear. 
Alvioli (in Foster 1968), Melvin and Tashjian (1969), and Care (1969) have 
ascribed it to the liberation of CT from the C-cells by glucagon. 
Bowser (1968) saw the hypocalcemic effect of glucagon after thyra-para-
thyroidectomy as well. Bernstein (1969) considers the presence of the thy-
roid gland unnecessary but that of the parathyroids to be essential for this 
induction. Williams et al. (1969) demonstrated that glucagon lowers the 
serum calcium level by promoting the uptake of calcium by the skeleton. 
It is known that calcitonin inhibits the release of calcium from bone. The 
hypocalcemic effect of glucagon injections has been proven (Berge & Alvioli 
1969). Paloyan et al. (1967•) succeeded in inducing parathyroid hyperplasia 
within six weeks in rabbits by glucagon injections. Recently, we have seen 
a patient with Cushing's disease, hyperparathyroidism, and a glucagon-
producing tumor in the pancreas. 
In pancreatitis, stimulation of the parathyroid glands is promoted not only 
by calcium-ion saponification and hyperglncagonemia but also by steator-
rhea, which is caused by exocrinic pancreatic insufficiency after recurrent 
pancreatitis. The parathyroid gland stimulation is then the result of 
inadequate vitamin D and calcium resorption from the gut (Davies et al. 
1956, 1968, Fisher et al. 1968). However, it may be difficult to distinguish cause 
from effect here, i.e. whether primary or tertiary hyperparathyroidism is 
concerned, since hyperparathyroidism can be complicated by intercurrent 
acute pancreatitis (Steyn et al. 1966, McLeod & Holloway 1967, Kelly & 
Falor 1968, Marks 1968, Warshaw et al. 1968). Carey and Fitzgerald (1968) 
have even described the familial occurrence of hyperparathyroidism with 
pancreatitis. Our series includes only one case of acute pancreatitis, which 
was diagnosed the day after the cervical operation. 
Sex hormones 
Primary hyperparathyroidism occurs preferentially in women in the 
menopause (Muller 1969). Conseqnently, an estrogen deficiency must 
be taken into consideration as a possible cause of primary hyperparathyroid-
ism. The plasma [PO 4] values and the phosphate excretion index do not, 
however, provide any indications for the existence of increased parathyroid 
activity in the menopause. \'!omen in menopause, whether natural or 
artificial, are more likely to develop osteoporosis than men of the same age 
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(Davis et al. 1966, Nordin et al. 1966). The histological characteristics and 
the chemical composition of the bone (Birkenhager & Birkenhager-Frenkel 
1968) are not the same in advanced senile osteoporosis and hyperparathy-
roidism, however. Therefore, the finding of the more frequent occurrence 
in women in the menopause does not contribute to the solution of the 
problem of the pathenogensis of primary hyperparathyroidism and senile 
osteoporosis. 
The explanation of this finding can at most be that women in menopause 
show a greater susceptibility for the development of primary hyperpara-
thyroidism or for a facilitated occurrence of the symptomatology than is the 
case for men of the same age. 
Other diseases 
Sarcoidosis is a non-hormonal disease that can occur together with primary 
hyperparathyroidism (Dent 1966, Pedersen 1967), but it is not clear whether 
there is a pathogenetic relationship between the two diseases involving a 
disturbance of the calcium balance or whether the concurrence is a matter 
of chance (Winnacker et al. 1969). Our series includes only one case of 
sarcoidosis, a woman with a demonstrated hyperparathyroidism in whom 
the diagnosis sarcoidosis was made as the result of a re-exploration made 
necessary by a possible recurrence of the hyperparathyroidism (see page 71). 
One of our patients in whom surgical treatment had been successful died 
later of a multiple myeloma. A similar case has been described by Cosgrove 
and Latourette (1953). Other concomittant diseases in our series were one 
case of mammary carcinoma, one of diabetes insipidus, and one of cholelithia-
sis. In view of the low frequency of the occurrence of these diseases in our 
material, we think the concomittance to be coincidental. We have also been 
unable to find reports of more than incidental concomittance in the literature. 
§ 3. HISTOPATHOGENESIS 
In addition to the local cell derailment in one parathyroid gland, which is 
expressed as a true solitary adenoma or parathyroid carcinoma, there is 
the primary hyperplasia. There are three hypothetical explanations for the 
simultaneous occurrence of hypercalcemia and primary hyperplasia; 
a. Incapacity for re-involution after hypocalcemia. 
b. A defect in the growth regulation of all parathyroid cells. 
c. A defect in the feedback mechanism of PTH secretion. 
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Fig. 1. Possible histopathogenesis of parathyroid tumors 
For the last two of these possibilities, a hereditary factor could be responsible 
It is not known, however, how often an external, partially obscure stimulus 
forn1s the pathogenetic moment. 
The most likely histopathogenesis of the parathyroid tumors in the 
presence of a chronic or intermittent stimulus is: normal-+ hypertrophy and 
hyperplasia -+ nodular hyperplasia -+ adenoma(ta) -+ carcinoma (Cope et 
al. 1958, Dent 1962, Golden et al. 1965, Black & Utley 1968, Davies et al. 
1968, Lloyd 1968, Kramer 1970). Between the transition from hypertrophy 
and hyperplasia to adenoma formation nodular hyperplasia might be 
considered an expression of dysplasia (Dr. R. 0. van der Heul, personal 
communication). 
As already mentioned, it is not impossible that in prolonged hypercalcemia 
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a certain degree of re-involution could occur, so that in long-term hyper-
parathyroidism, parathyroid tissue that has become autonomous, via the 
hypercalcemia forces the hyperplastic tissue to re-involution (see Fig. 1). 
Once this has occurred, the single adenoma has originated. The reason why 
we see more and more hyperplasias or enlargement of all the glands would 
be that for the development of the observed histological picture a certain 
lapse of time and thus a certain duration of the disease is required. 
The earlier the diagnosis hyperparathyroidism is made, the more often 
hyperplasia will be found (Cope et al. 1958), the later the more often ade-
noma. This is in agreement with the current more rapid and earlier recog-
nition of hyperparathyroidism and with the fact that enlargement of more 
than one gland is found with increasing frequency. 
This conception of the histopathogenesis again raises the problem of our 
lack of information concerning the stimulus leading to parathyroid hyper-
plasia. If the development of the histological picture is not the result of 
hypocalcemia alone but of other factor as well, the pattern and duration 
must be determined by the opposite influences of these factors and a possible 
hypercalcemia. 
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§ 1. 
Chapter VI - Suspicion and diagnosis 
of hyperparathyroidism 
Before specific steps can be taken to arrive at a diagnosis, hyperparathyroid-
ism must be suspected. The first step is extremely difficult. In early cases the 
symptomatology is vague. Bradshaw (1966) calls the disease 'the syphilis 
of the endocrine system'. It often amounts to a summation of symptoms 
pointing in the direction of hyperparathyroidism (Cope 1966). These 
symptoms are caused by the hypercalcemia (Swyer et al. 1950), nephrolithia-
sis, kidney function disorders, and bone anomalies (Smeenk & Muller 1961). 
Familiarity with the clinical picture has led to earlier diagnosis at present. 
As a result, there has been a change in the relevant symptoms described by 
St. Goar (1957) as 'a disease of stones and bones ... recognized earlier and 
more frequently ... as a disease of stones, bones, and abdominal groans', 
to which Mieher et al. (1961) added 'psychic moans' and Boonstra and 
Jackson (1956) 'fatigue overtones'. 
Another comparison with syphilis can also be made. In asymptomatic 
lues the disease process can show marked progression, although only the 
serological reactions are positive. Similarly, we know asymptomatic hyper-
calcemia with progressive nephrocalcinosis and impaired kidney function. 
Nephrolithiasis, too, does not always produce symptoms. Since early 
diagnosis can prevent potentially lethal kidney damage or keep it to a 
minimum, it will be useful here to mention the signs and symptoms that 
should cause suspicion of hyperparathyroidism (Cope 1966, Graham & 
Royster 1967). It should be said first and foremost that when there is even 
the least doubt, the indication for determination of the plasma [Ca] is already 
present. 
Kidney stones: 
Retrospectively, urolithiasis is found to occur in hyperparathyroidism in 
about 70% of the cases (Cope 1966, Smeenk 1968), and 2.5 tot 5% of all 
patients with kidney stones have hyperparathyroidism (McGeown 1963, 
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Adams et al. 1965). Suspicion should certainly be entertained when there 
are bilateral and recurrent kidney stones containing calcium, especially when 
no local cause, such as obstruction or infection, is present (Keating 1962, 
Hodgkinson & Edwards 1963, Bartelheimer & Kuhlencordt 1967, Sonoda 
et al. 1967, Yendt & Gagne 1968). 
Digestive tract: 
Weight loss due to anorexia, nausea and vomiting, constipation, polydipsia, 
and polyuria, may offer the only key to the diagnosis (Mieher et al. 1961, 
Cope 1966). Stomach complaints vary from vague pain to the typical peptic 
ulcer complaints and those associated with acute pancreatitis. 
The number of ulcer patients among the hyperparathyroidism patients 
is not known with certainty. The reports range from 8 to 43% (Cope 1966, 
Marks 1968, Myers & Bhatti 1970). Typical ulcer complaints are not always 
accompanied by a radiologically demonstrable lesion (St. Goar 1957). It has 
never been conclusively demonstrated that the occurrence of peptic ulcer 
is promoted by hyperparathyroidism (Gray 1964). In all likelihood, gastrin 
production is unremittingly stimulated by hypercalcemia (Trudeau & 
McGuigan 1969). 
But ulcer cases have two striking aspects that make the presence of hyper-
parathyroidism more probable: 
a. when the complaints do not improve or even become worse on a milk 
diet (Keating 1962, Katz et al. 1964), and 
b. when a duodenal ulcer is demonstrated in a woman (Gray 1964, Gold-
smith et al. 1966, Ellis & Nicholoff 1968). 
Pancreatitis: 
Pancreatitis can, albeit infrequently, be an expression of hyperparathyroid-
ism, especially when no cause can be demonstrated for the pancreatitis 
(Cope 1960, Coffey et al. 1965, Marks 1968). This may concern the form of 
hyperparathyroidism called parathyroid intoxication (Kelly & Falor 1968). 
Therefore, a normal plasma [Ca J in a patient with a severe acute pancreatitis 
is suggestive of hyperparathyroidism, and it is advisable to determine 
the plasma [Ca] regularly during convalescence (Coffey et al .1965). 
Neurological and psychiatric phenomena: 
When sought for, hypotonia and myasthenia are found (Cope 1960, Buge & 
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Mignot 1964, Smith & Stern 1967, Frame et al. 1968). Subjective findings 
such as weakness, headache, fatigue, apathy, lack of initiative, and de-
pression develop gradually (Karpati & Frame 1964, Anderson 1968, Petersen 
1968). Hypercalcemic crises are often accompanied by alarming phenomena 
such as disorientation, psychosis, and coma (Horeau et al. 1965, Bauer-
meister et al. 1967, Marks 1968). Such patients sometimes are even placed in 
psychiatric institutions. 
Electrocardiogram: 
When the plasma [Ca] rises above 12.5 mgj100 ml, a pathological 
shortening of the QT interval occurs (Cope 1960, Boen et al. 1962). 
Metastatic calcifications: 
Not only nephrocalcionosis but also calcification of the conjunctiva, ear 
drum, and peripheral arteries may occur. Bandkeratopathy may also de-
velop due to calcification (Cogan et al. 1948, Cogan & Henneman 1957, 
Coffey et al. 1965). 
Neonatal tetany: 
Neonatal tetany may be the only expression of maternal hyperparathyroid-
ism. It is caused by a secondary hypoparathyroidism in the infant, leading 
to hypocalcemia, sometimes with hypomagnesemia (Ertel1969). The earliest 
convulsions may occur in the third week after birth (Mannix & Loer 1968, 
Rubin et al. 1968), but sometimes much later (Friderichsen & Rosendal 
1968). 
Bone: 
Like bone pain, bone cysts (brown tumors), resorption of the lamina dura, 
and malocclusion are not early symptoms of hyperparathyroidism. Never-
theless, when they cannot be explained in any other way, they may suggest 
hyperparathyroidism to the dentist or otorhinolaryngologist (Boyle 1962, 
Thompson 1964, Anderson & Lindholm 1967, Houston et al. 1968). 
Multiple endocrine adenomatosis: 
Patients suffering from acromegaly, hyperthyroidism, insulinoma, Zollinger-
Ellison's syndrome, Cushing's disease, or any combination of these diseases 
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should be investigated for hyperparathyroidism (Wermer 1954, 1963, 
Vancil & Locke 1965). This also holds for all forms of thyroid disease 
(Feind 1964, Laing et al. 1969, Heimann et al. 1970b). 
Familial hyperparathyroidism: 
When a patient suffering from hyperparathyroidism has a suggestive family 
history (e.g. ulcers, urolithiasis), further investigation of kin is certainly to 
be considered (Cutler et al. 1964, Schachner et al.1966, Graber & Jacobs 1968). 
§ 2. THE DIAGNOSIS 
As a rule, the diagnosis primary hyperthyroidism is made by exclusion and 
is only confirmed in the last phase, i.e. the exploration. Many authors are 
in agreement that the demonstration of hypercalcemia is fundamental for 
the diagnosis (Keating 1962, The Lancet: Leading Article 1965, Graham & 
Royster 1967, Smeenk 1968). 
This is where the first difficulties arise. The patient's plasma [Ca] may 
fluctuate, so that this determination should be done repeatedly (Hodg-
kinson & Edwards 1963, Sonoda et al. 1967, Renwick et al. 1968, Finby & 
Begg 1969). A correction must be made for determination errors caused by 
hemoconcentration (Cope 1960, McGeown 1961, Dent 1962). Hemoconcen-
tration (due to venous congestion) causes a rise in the plasma [Ca] 
proportional to the total protein in the plasma. For each gram that the total 
protein increases per 100 ml plasma due to hemoconcentration, the total 
plasma [Ca] rises by 0.5 mg calcium per 100 ml plasma (Smeenk & van den 
Brand 1965, Smeenk 1968). Furthermore, hypercalcemia may be masked 
or compensated by high phosphate intake (Eisenberg 1968), hypalbumine-
mia, impaired renal function, or acute pancreatitis. 
There is also the possibility of normocalcemic hyperparathyroidism, which 
can give rise to the same complications as hypercalcemic hyperparathyroid-
ism (Keating 1962, Nichols & Flanagan 1967, Eisenberg & Goth 1968, 
Melvin et al. 1968, Fisher et al. 1969, Wills et al. 1969). 
The hypercalcuria, elevated renal phosphate clearance, and hypophos-
phatemia occurring in primary hyperparathyroidism may be absent (even 
with adequate kidney function) but can also occur without hypercalcemia 
in the so-called idiopathic hypercalcuria. A specific functional test for the 
demonstration of an autonomous hyperfunction of the parathyroid glands 
is therefore urgently needed, but a test of this kind is not yet available. 
It has indeed been remarked in a leading article in The Lancet that: 'The 
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number of diagnostic tests varies inversely with their specificity. Thus, 
tests for primary hyperparathyroidism abound'. 
A solution to these problems seemed to be offered by the use of a radio-
immunoassay for direct measurement of the plasma [Ca], but overlapping 
proved to occur between the values found in normals and in patients suffer-
ing from hyperparathyroidism. In about 50% of the investigated patients 
a normal plasma [PTHJ was found. Furthermore, the PTH levels are higher 
in secondary than in primary hyperparathyroidism (Berson & Yalow 1967, 
Egdahl1968, Lequin 1969, Arnaud 1970, Arnaud et al. 1971). 
When hypercalcemia is demonstrated either by chance or preferably by 
screening in a patient with nephrolithiasis andjor skeletal changes as well 
as a so-called hypercalcemia syndrome, the only course open - in view of 
the lack of adequately reliable positive diagnostic methods - is to attempt 
to exclude the numerous causes of hypercalcemia other than primary 
hyperparathyroidism (see e.g. Smeenk & Muller 1961, Keating 1962). 
These include sarcoidosis, myelomatosis, carcinomatosis with or without 
radiographically demonstrable skeletal metastases, reticulosis, leucemia, 
immobility osteoporosis, Paget's disease with immobilization, hypercorti-
solism, hyperthyroidism, adrenal insufficiency, vitamin D intoxication, and 
the milk-alkali syndrome in peptic ulcers. 
The anamnesis, physical examination, and routine tests will of course 
determine the direction in which the differential diagnosis must be sought, 
for example the finding of hepato-splenomegaly or swelling of lymphatic 
glands (or radiographically only of the hilus glands). Particularly in sarcoi-
dosis but also in most of the other conditions, the plasma [Ca] can be 
normalized with the so-called cortisone test according to Dent (1961, 1968). 
The protein spectrum may provide indications with respect to sarcoidosis 
and myelomatosis, The tuberculin test results should be considered too. 
The radiological investigation of the skeleton can give clues pointing to 
myelomatosis or carcinomatosis of the skeleton. In rare cases the radiograms 
may offer specific indications for primary hyperparathyroidism itself. 
Cytological or histological investigation of the bone marrow (with respect 
to myelomatosis, reticulosis, skeletal metastases, or aleucemic leucemia) 
will only be required in a minority of the cases. When there is any doubt 
at all, it is advisable to apply a reliable parameter for the thyroid gland 
function, such as P.B.I. or total thyroxin content. Adrenal insufficiency, 
which never is accompanied by a severe hypercalcemia, is easy to recognize 
clinically. Excessive use of vitamin D or of milk and alkali can as a rule be 
detected from the history. 
Positive diagnostic data - albeit not always specific for primary hyper-
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parathyroidism (see e.g. Goldsmith 1969) - can be found in the form of 
hypophosphatemia, an elevated serum alkaline phosphate level, elevated 
phosphate clearance or depressed tubular resorption of phosphate, increased 
excretion of hydroxyproline in the urine, and radiological signs of bone 
resorption at certain sites of predilection such as the cortices of the pha-
langes, the distal ends of the clavicles, and the lamina dura of the tooth 
sockets. The presence of hypercalcuria has virtually no differential-diag-
nostic importance in relation to the hypercalcemia. When necessary, these 
diagnostic methods can be supplemented by histological investigation of a 
biopsy sample from the iliac crest, since it has been found that in a high 
percentage of the cases (i.e. even when no skeletal changes can be demonstra-
ted radiographically) in primary hyperparathyroidism the bone shows signs 
of increased formation and destruction expressed in, among other things, an 
increased uptake of tetracyclin (van der Sluys Veer et al. 1964). The 
possibilities and limitations offered by the radio-immunological determi-
nation of the parathyroid hormone level in the serum has already been 
discussed above. 
A special diagnostic problem is formed by the syndrome of the ectopic 
parathyroid hormone production, sometimes called pseudo-hyperpara-
thyroidism (Lafferty 1966). Although this is well known for carcinoma of 
the kidney, bronchus, and ovary, and for reticulosis, the syndrome can 
develop in many other malignant processes. Even in cases of long-standing 
hyperparathyroidism, the possibility of renal carcinoma should be excluded. 
With all this, however, we have barely touched on the diagnostic problems 
associated with hyperparathyroidism. The decision to operate must never 
be taken except on the broadest possible basis, which will be discussed 
exhaustively in the publication already referred to (D. Smalbraak, in prepa-
ration). 
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Chapter VII - Incidence of 
primary hyperparathyroidism 
Ten years ago, primary hyperparathyroidism was still considered to be a 
relatively rare disease. Autopsy results have shown, however, that the 
diagnosis is often missed during the patient's life (Norris et al. 1947). Bay et al. 
(1967) found a parathyroid adenoma in2% of a series of 350 routine autopsies, 
and Vail et al. (1967) primary and secondary enlargement of the parathyroid 
glands in 12% of a similar series of 200. In addition, parathyroid tumors 
are sometimes fonnd by chance during thyroid gland operations (Feind 1964, 
Attie et al. 1967, Davies et al. 1968, Laing et al. 1969, Heimann et al. 1970•). 
A case of this kind occurs in our material. A 49 year old woman underwent a hemi-
thyroidectomy on the left side. Pre-operatively, both the plasma [Ca] and alkaline 
phosphatase value were normal (9.4 mg/100 ml and 10.8 U.K.A., respectively). 
At operation, besides a diffuse, nodular goiter, enlargement of the left parathyroid 
glands (400 mg and 100 mg) was found. A hemithyroidectomy on the left and a 
resection of 2-} parathyroid glands were performed. Post-operatively, the plasma 
[Ca] was 8.3-9.4 mg/100 mg. The pathologist's report read: water-clear cell 
hyperplasia of the parathyroid glands, nodular dysplasia of the thyroid. Previously, 
this patient had never had a single complaint pointing in the direction of hyper-
parathyroidism. 
There are cases in which suspicion of the disease arises because of a coinci-
dental determination of the plasma [Ca] (Dent 1962, Keating 1962). 
Since the introduction of routine calcium determination in all patients, 
primary hyperparathyroidism has been diagnosed much more frequently 
(McLellan et al. 1968, Myers & Bhatti 1970). Boonstra and Jackson (1965) 
give a good impression of the incidence of the disease: in 25,84 7 successive 
patients, determination of the plasma [Ca] led to the diagnosis of primary 
hyperparathyroidism in 31 cases. This study did not include patients 
referred for further evaluation of a hypercalcemia. It was also found that 
23 of these 31 patients had had only vagne complaints. In a similar study 
in 2,005 patients, Keating et al. (1969•) found 7 cases of hyperparathyroid-
ism, 3 of which had had an asymptomatic course. Thus, the incidence of 
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primary hyperparathyroidism among hospital out-patients appears to be 
of the order of 1.2 to 3.5%,; 0.9 to 1.5%, of the patients had an asymptomatic 
or symptom-poor form of primary hyperparathyroidism. These data seem 
to provide sufficient argumentation for the importance of routine determi-
nation of the plasma [Ca]. 
Age: Primary hyperparathyroidism can develop at any age. It is rare in 
children as well as after the age of 75 (Fanconi & Mieth 1967, J\!Iiihlethaler 
et al. 1967). The highest frequency is found in the age-group of 30-65 years 
(Norris 1957, Cope 1960). This also holds for our material. 
Sex: Primary hyperparathyroidism occurs twice as often in women as in 
men (Cope 1960, Hellstrom & Ivemark 1962, Lloyd 1968), but before puberty 
there is no preference for either sex (Miihlethaier et al. 1967). For the first 
200 patients of the present series, after correction for the composition of the 
population, Muller (1969) reported a slightly higher frequency in male than 
in female patients up to the age of 45. After this age, however, there is a 
sharp increase in the incidence in women (see Fig. 2). 
In men the normal upper limit of the plasma [Ca] drops with increasing 
age, but this shift is not seen in women. Keating et al. (1969b) found the 
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Fig. 2. Histogram showing the distribution of hyperparathyroidism according to age and 
sex (with the publisher's permission, from The Lancet nr. I: 449-450, 1969). 
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upper limit in 80 year old men to lie 0.4 mgflOO mllower than that for 20 
year old males. Since these data were not known to us at the time, it remains 
possible that we missed the diagnosis more often in older men than in older 
women. 
Our 255 cases of proven primary hyperparathyroidism included 160 wo-
men and 95 men (62.8 and 37.2% respectively). This means a ratio of 
1.68 : 1. The age distribution for both sexes is given in Fig. 3; no correction 
for the composition of the population was applied here. 
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Fig. 3. Age distribution of 255 primary hyperparathyroidism patients, according to sex. 
Here too the virtually symmetrical curve for the males is striking, the 
females giving rise to an asymmetrical curve with a sharp peak after the 
age of 45. Below this age, the incidence is almost the same for both sexes 
(47 women, 51 men); above it, the incidence is 2.5 times higher in women. 
To reach a conclusion concerning a possible pathophysiological relation-
ship between age, sex, and the etiology of primary hyperparathyroidism, 
it is recommendable that a curve of this kind be constructed, using the 
estimated age at which the disease began. These data for the present 
material are being analysed and will be given in the thesis mentioned above 
(see Introduction). 
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Chapter VIII The surgical technique 
The golden opportunity to find a 
small parathyroid adenoma lies in the 
first surgical exploration of the neck. 
Churchill and Cope (1934) 
When the surgeon is convinced that primary hyperparathyroidism has been 
correctly diagnosed, surgery is the treatment of choice. Technically, the 
operation offers two main problems; first, to find the glands; and second, 
how many and which glands should be resected. In order to arrive at the 
most logical form of operation on the basis of present knowledge of para-
thyroid tumors, these two points must be analysed. 
In addition, it is of paramount importance to succeed with the first 
operation, not only to spare the patient a second procedure and to put an 
end to the progressive kidney damage but also because re-exploration means 
that dissection must be done in tough connective tissue containing many 
lymph glands, which appreciably complicates the second operation. Under 
these conditions the surgical field is more difficult to survey and the chance 
of camouflage by minor hemorrhages is increased. Furthermore, lesions of 
the recurrent laryngeal nerve are more likely to occur at re-exploration 
(Baehrs & Vandertoll 1963). It must also be kept in mind that since the 
enlarged parathyroids were missed at the first exploration, there is a greater 
chance that an abnormal localization is involved. 
Finding the glands 
The operation is performed under intratracheal anesthesia. The head is 
fixed in a position with slight extension of the neck. The use of a pillow 
under the shoulders is not recommendable: little is gained with respect to 
the field of vision, and the patient may have severe complaints for many 
months clue to the hyperextension of the neck during what is sometimes a 
very long operation. After a transverse collar incision has been made, the 
skin flaps are mobilized proximally and distally over a considerable distance. 
Next, the superficial fascia and platysma are divided. The sternohyoid, 
omohyoid, and sternothyroid muscles are divided and dissected from the 
thyroid gland. 
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It can be difficult to find normally situated parathyroid glands, because 
they may be hidden in or behind fat lobules or connective tissue behind 
the thyroid gland. To obtain a good view of the entire space behind the 
thyroid gland, the entire gland must be adequately mobilized. If present, 
the middle thyroid vein must be divided (Hellner 1965), after which the 
inferior thyroid artery must be found and ligated. 
The most frequent complication accompanying operations in this region 
is paralysis of the vocal cords. To prevent this, the last step before starting 
the exploration proper is to locate and dissect free the recurrent laryngeal 
nerve in the region of the larynx and the upper part of the trachea. This 
step is also useful for finding the parathyroids (see page 9). 
This is the point at which the search for both the normal and enlarged 
parathyroids begins (Muller, personal communication). The lobe of the 
thyroid is turned over to the other side by pulling with a tissue forceps. The 
parathyroids can be distinguished by their slightly darker yellowish-brown 
color and finely granular appearance as compared to the fat tissue. They 
are attached to the thyroid gland, but are further independently mobile. 
If blood appears in the surgical field, the surrounding tissue acquires the 
same darker color as the parathyroids, thus camouflaging them. Conse-
quently, it is imperative to dissect carefully, without causing any bleeding 
or excising any tissue unnecessarily. For this, time and patience are in-
dispensable (Black 1963, Cope 1964, Davies 1966). 
To keep the surgical field as free of blood as possible, an artificial re-
duction of the systolic blood pressure to 80-90 mm Hg can be induced by 
infusion of trimethanecamphorsulfonate (ArfonadR) when no contra-
indications to this are present (myocardial or cerebral ischemia). In our 
series its application did not lead to any complications in the sense of a 
cerebrovascular accident, myocardial infarction, or kidney damage, even in 
cases with prior hypertension. This artificial reduction of the blood pressure 
is of great value in re-exploration: the presence of marked fibrosis in the 
neck region can result in so much oozing of blood in the surgical field that 
dissection may be virtually impossible unless hypotension is applied. 
The upper parathyroids are sought first in the normal localization and 
then the lower glands, the entire posterior surface of the thyroid being 
inspected. "When they are not found there, inspection and palpation of the 
thyroid may even in this stage lead to suspicion of an intra-thyroidal tumor. 
Next comes exploration around the trachea and esophagus and in the 
prevertebral space, in the cranial, caudal, and lateral directions. Lastly, 
the carotid sheath is opened and inspected. 
The procedure is of course terminated as soon as the upper and lower 
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parathyroids have been found. The glands are then very carefully dissected 
free of the surroundings so that their size can be judged. This care is imper-
ative because the vascularization via the hilus is often difficult to distinguish. 
A small biopsy sample is taken, as far as possible from the hilus, from all 
structures that might be parathyroids, and immediately examined in frozen 
sections. Enlarged glands are not excised at this time. First, the same 
procedure is carried out on the other side. Lastly, even if four glands have 
been identified, with confirmation from frozen sections, the thymus is 
inspected and in adults usually excised, because it may contain normal or 
enlarged supernumerary parathyroids. At the same time, the field must 
be examined for abnormal vessels running in the caudal direction. 
The surgical approach to mediastinal tumors with a possibly intra-thymic 
localization can be made in two ways, either from the cervical incision or by 
means of a sternotomy. Via the cervical incision and with blunt dissection 
behind the manubrium sterni, both thymus glands are brought forward and 
upward, inspected, and if necessary excised (Black 1952, Hellstrom & 
I vemark 1962, Adams & Murphy 1963, Higgins 1964, Albo & Stevens 1968, 
Nathaniels et al. 1970). It is our experience that with this approach the 
retrosternal space can usually be surveyed up to the level of the innominate 
artery. With this method, up to 95% of all mediastinal tumors can be excised. 
For more caudally localized tumors, sternotomy is required in 1.7 to 5% of 
the cases (Black 1963, Hellstrom 1965, Davies 1966, Nathaniels et al. 1970). 
Since recovery from hyperparathyroidism after a negative neck explo-
ration has been described several times (probably being due to accidental 
destruction of the vascular supply of the tumor), there is no agreement in 
the literature whether, after a negative neck exploration, a sternotomy must 
be performed immediately during the same operation. Some authors do this, 
others wait for 6 to 12 weeks to see whether a spontaneous improvement 
occurs. If it does not, a sternotomy is performed in a second operation. In 
our experience a sternotomy is very rarely necessary: As will be mentioned 
(page 63) even very deep-lying intrathymic parathyroids can be removed 
via the cervical incision. Extrathymically localized retrosternal parathyroid 
glands rarely occur. 
Only when there is a clear-cut indication for a mediastinal tumor (e.g. by 
the presence of an abnormal vessel or a suspicious shadow on the thoracic 
radiogram or tomogram of the mediastinum) or when at re-exploration the 
amount of fibrosis is so great that exploration via the cervical incision is too 
dangerous, is a sternotomy performed at the same operation. For this 
operation the sternum is usually divided longitudinally as far as the third 
intercostal space. 
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If the sternotomy is to be performed in a separate procedure, we have 
found it better to postpone this operation for at least three months when 
there is no compelling reason to operate as soon as possible. If the operation 
is done sooner, the tissue reaction and fibrosis in the neck make good 
anatomical exploration extremely difficult and it is imperative that all the 
structures in the neck be dissected again. 
Of the abnormal localizations in which both the upper and the lower 
parathyroids can be found, the intra-thyroidal is by far the most important 
after the retrostemal. The former localization is found in 1 to 7% of the 
patients (Norris 1947, Black 1952, Hellstrom & Ivemark 1962, IIiggins 1964, 
Marks 1968, Goodman et al. 1969). Like the mediastinal localization, the 
intra-thyroidal should be suspected whenever a gland cannot be found. 
The suspicion is strengthened when a lobe of the thyroid gland shows local 
discoloration or enlargement and when a lump is found at palpation. In 
that case the tumor can be removed via an incision through the thyroid capsule 
(thyroidotomy). Sometimes, thyroidotomy makes better palpation possible. 
We prefer the following procedure. The thyroid arteries are temporarily 
ligated and an incision is made on the anterior surface of the lower lobe. At 
this stage we have had the experience several times that the enlarged 
parathyroid literally popped out of the thyroid. Finally, if a gland remains 
unfound, a 'blind' unilateral resection of the upper or lower lobe of the thyroid 
can be performed (Black 1963, Coffey et al. 1965). When two out of four 
glands are still missing, a bilateral upper or lower lobe resection can be 
performed or a hemithyroidectomy (Black 1952, Hellstrom & I vemark 
1962, Pyrah et al. 1966, Goodman et al. 1969). 
We consider total thyroidectomy, as advocated by a few authors for an 
elusive tumor, to be a technical error. 
The resection 
Second only to the problem of finding the parathyroids, the greatest problem 
in parathyroid surgery is the question of how many of these glands should 
be removed. If primary hyperplasia did not have to be taken into account, 
the solution would be simple: the enlarged glands (adenomas) could be 
resected, the normal glands left undisturbed. But the discovery of primary 
hyperplasia by Cope et al. in 1958 was not only important with respect to 
the pathogenesis of the disease. The realization that it is imperative that all 
the parathyroids must be found at exploration led to the finding of more 
tumors in each patient and therefore to a smaller percentage of failures. 
A steadily increasing number of investigators are of the opinion that in 
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primary hyperparathyroidism, primary hyperplasia is originally present, 
so that all the glands are potentially affected. The consequence of this is 
that in principle a subtotal parathyroidectomy (resection of 3;! glands) 
would have to be performed. Persistence or rec12rrence of the disease due to 
hyperfunction of the glands considered normal at the first operation would 
thus be prevented (Cope 1966, Muller et al. 1966, Block eta!. 1967, Utley & 
Black 1967, Lloyd 1968, Graber & Jacobs 1968, Rienhoff et a!. 1968, Straus 
& Paloyan 1969, Kramer 1970). But the reverse of the medal is that the 
consistent perforrnance of subtotal parathyroidectomy brings with it the 
high risk of permanent post-operative hypoparathyroidism. This means life-
long treatment with dihydrotachysterol and possibly calcium, with frequent 
determination of the plasma [Ca]. But if the subtotal operation is not 
perforrned, there is the threat of recurrence. It is between this Scylla and 
Charibdis that the surgeon is forced to navigate without a compass. For the 
present, at least, pre-operative prediction of the pathological substrate 
remains impossible. 
A prospective double-blind study has not yet been performed to investigate 
the value of subtotal parathyroidectomy. Paloyan et al. (1969) compared 
the results obtained since 1965 in 26 patients in whom subtotal parathy-
roidectomy had been performed for suspected primary hyperplasia with the 
results obtained before 1965 in 27 patients in whom only enlarged para-
thyroids had been removed. vVith the radical treatment the number of 
recurrences dropped from 15% (4 patients) to nil. Remarkably enough, 
post-operative persistent hypoparathyroidism also dropped: from 19% to 
8%. These results must be interpreted with a certain amount of reserve. 
For one thing, the interval between the first operation and the diagnosis of 
the recurrence is not mentioned. This makes the differentiation between 
true recurrences and latent failures due to the missing of enlarged glands im-
possible. The improvement of the results in what is actually a small series 
could furthermore be at least partially due to the accumulation of experience. 
The group of pre-1965 patients were operated on by different surgeons, 
most of the post-1965 group by the same one. The improvement in the 
results could even be explained solely on the basis of the fact that after 1965 
every attempt was made to expose all the glands and to take biopsy samples. 
Our own approach is the following. After attempting to expose all fonr 
parathyroids, biopsy samples are taken from them. When the pathologist 
confirms the diagnosis parathyroid tissue, the situation is re-evaluated and a 
plan is made for the resection, the objective being to reduce the amount of 
parathyroid tissue to the quantitatively (and preferably qualitatively as 
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well) normal amount of tissue (100-150 mg}. As has already been argued, 
we do not base this consideration on the histological picture shown by the 
frozen section. Abnormally large glands are taken as pathological. Grossly 
normal-appearing glands are left undisturbed (IVIuller et al. 1966}. The 
decision as to which glands must be removed now has two aspects: one with 
respect to cases in which there is a normal gland or glands, the other apply-
ing to cases in which no normal parathyroids are present. 
Tumors in combination with normal glands. 
When the surgeon is convinced that good vascularization of the normal 
parathyroid tissue is assured, there is no difficulty. The enlarged glands are 
resected. If the vitality of the sole remaining normal gland is not certain 
(as may occur when three tumors are found), a small part (50 mg} of the 
gland with the most distinctly healthy and undamaged vascular pedicle can 
be left behind. 
All exposed glands are enlarged 
vVhen all four glands are enlarged, a subtotal resection must be performed 
and part of the least enlarged gland is left behind (100 mg). If the vitality 
is dubious or this gland would be difficult to find again at a possible later 
exploration, part of another gland can be left behind instead. (For the same 
reason, in divergence from our principle, we occasionally excise an abnorm-
ally localized, apparently healthy gland to avoid difficulties in case of a later 
recurrence} . 
The situation becomes much more complicated when one or two enlarged 
glands are found at exploration but the others cannot be located. In our 
material this occurred in four patients not previously explored. Our ex-
perience was then still rather limited, since these four patients were among 
the first few of the series. It is difficult to form an opinion about unexposed 
glands. It can only be said that the more thorough the exploration the less 
the chance that such glands have remained undamaged. For this reason we 
do not advocate blind excision of all the fibre-areolar tissue behind the 
thyroid gland. This practice increases the chance of removing a normal gland 
where careful exploration would certainly have revealed an enlarged gland 
if present. 
The situation in which only enlarged glands are found is often encountered 
when an exploration or thyroidectomy has been done previously. It is of 
course of paramount importance to know whether, and if so which, para-
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thyroid(s) were removed at that time. Unless the previous surgical report 
and histological data are available, are-exploration is unnecessarily difficult 
and dangerous. In the absence of detailed information and when only tumors 
are found at exploration, it is safest to assume, after a thorough search, 
that any missing glands must have been previously removed. In these cases, 
therefore, a subtotal resection of the exposed tumors should be performed. 
We wish to emphasize once again that a re-exploration - whether per-
formed because of recurrence or failure - will proceed much more smoothly 
if the surgeon has been able to obtain complete information about the 
previous surgical findings. It is therefore imperative that the surgical report 
include au accurate drawing of the situation encountered with indication 
of the removed glands (Muller et al. 1966). In some cases it may be wise to 
place metal clips next to the glands left in situ, in case of recurrence (Feind 
1964, Adams et al. 1965, Block et al. 1967, Black & Utley 1968, Graber 
& Jacobs 1968, Rienhoff et al. 1968). This holds especially for marking 
remnants of subtotally removed tumors. 
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Chapter IX - Analysis of the findings 
in 267 patients 
Of the 267 patients whose clinical histories were studied, a few were not 
suitable for detailed analysis. One of these patients was operated on to 
confirm the diagnosis essential hypercalcuria, because he was a youug man 
and the kidney function was already so poor that several parameters could 
not be used. At operation, four normal parathyroid glands were found. 
In another patient, a woman with a severe renal disease and secondary 
parathyroid hyperplasia, a subtotal resection was performed to relieve 
insupportable itching. A third patient underwent subtotal resection for a 
secondary hyperparathyroidism which had become autonomous (i.e. tertiary 
hyperparathyroidism) after a successful kidney transplantation. 
Four patients underwent an exploration on erroneous grounds. One of 
these had a pseudo-hyperparathyroidism with all the phenomena of primary 
hyperparathyroidism, due to carcinoma in a kidney that had not functioned 
for the past ten years. The other three had sarcoidosis with hypercalcemia, 
which had not been diagnosed despite thorough investigation. The diagnosis 
could only be made on the basis of histological investigation of the lymph 
glands found along the trachea during exploration. In all four patients four 
normal parathyroid glands were found and in one case the diagnosis sarcoi-
dosis was made on the basis of the biopsy sample of one of the parathyroids. 
Lastly, the exploration failed in 5 patients, mainly because of the very 
marked fibrosis in the neck as the result of earlier exploration(s) done else-
where. From the clinical data we must assume that they were indeed 
suffering from a primary hyperparathyroidism (see Table III). 
In two referred patients with persistent hypercalcemia after the removal of 
one or more enlarged parathyroids, no tumor was found at our re-exploration 
The operation had to be terminated prematurely due to complications. These 
last two patients will be discussed in connection with the series of patients 
with proven hyperparathyroidism. 
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Table III. The material of the present study. 
No. of % No. of % 
patients patients 
Our own patients 236 88.4 
Referred patients 
Explored once elsewhere 26 9.7 11.6 Explored twice elsewhere 5 1.9 31 
Total number of patients 267 100.0 
As already mentioned, the clinical and biochemical diagnosis of our 
patients will not be considered here because they are the subject of a sepa-
rate study. Here, it need only be mentioned that with increasing experience, 
exploration was decided upon sooner and more easily, even when according 
to the out-moded criteria the hypercalcemia would be called slight. 
Table IV. Principal signs and symptoms in 255 patients with 
hyperparathyroidism.* 
Sign/Symptom No. of patients 
Urolithiasis 150 
Pyuria 6 
Hypertension 4 
Bone pain or pathology 20 
Peptic ulcer 21 
Stomach pain 4 
Anorexia 10 
Nausea 25 
Vomiting 26 
Constipation 15 
Thirst 10 
Polyuria 11 
Fatigue 37 
Depression 1 
Psychosis 2 
Pre-coma 1 
Coma 1 
Accidental finding 20 
Family investigation 2 
* The total number is higher than255 because many of the patients had more than one. 
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In the majority of the cases, as could be expected, the signs leading to 
suspicion of hyperparathyroidism was kidney stones, but also an un-
explained pyuria or epididymitis. The remaining indications represent 
the entire scale of the already mentioned 'bones ... , stones ... , abdominal 
groans ... and fatigue overtones' (see Table IV). 
It is striking to note that in about 8% of the patients the diagnosis was 
made by chance. 
There were 255 patients in whom the diagnosis primary hyperparathyroid-
ism could be made with certainty (see page 59). The youngest patient was 
10 years old, the oldest 79. The men numbered 95 and the women 160. For 
the distribution according to age and sex, see Fig. 3 (page 41). 
Initially, the number of patients treated annually was small, but after 
1961 there was a marked increase (see Table V). 
Table V. Distribution of operations for hyper-
parathyroidism over 5-year intervals from 
7 950 to 7 970. 
Period No. of patients 
1950-1954 12 
1955-1959 25 
1960-1964 65 
1965-1969 165 
Total 267 
In the following pages the surgical findings will be discussed, including 
the total number of parathyroids found, the localization of normal and ab-
normal parathyroids, the technique of the resection, the complications 
arising during surgery, the mortality, and the late results. 
§ 1. LOCALIZATION OF THE PARATHYROID GLANDS IN 267 PATIENTS 
In the following, the term tumor is used in the purely Latin sense of a swelling, 
with no pathological differentiation implied. 
As already mentioned (see page 7), the localizations of 939 glands were 
available for analysis. Of these, 235 (25%) lay outside the previously de-
scribed normal area, 86 of them against the posterior surface of the thyroid 
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gland or rather close to the lower pole of the thyroid gland. At exploration 
this localization gave little or no difficulty, and these glands are therefore 
classified as subnormal (see Table VI). 
Table VI. Localizations of 939 parathyroid glands as found 
at operation. 
Localization No. of glands 
Normal 704 
Subnormal 86 
Abnormal 149 
% 
75.0 
9.2 
15.8 
Total 939 100.0 
--····-··--·-·--
This leaves 149 highly unusual localizations whose distribution is shown in 
Table VII. 
Table VII. Abnormal localization of parathyroid glands in our material. 
Localization 
Intra-thymic 
Anterior mediastinum 
Posterior mediastinum 
Retro-thyroidal 
Intra-thyroidal 
Ante-thyroidal 
Total 
No. of glands 
79 
23 
19 
10 
17 
1 
149 
% 
53.0 
15.4 
12.8 
6.7 
11.4 
0.7 
100.0 
Table VII shows that the number of retrosternally located glands (i.e. in 
the thymus and mediastinum) amounts to 79 + 23 + 19 = 121, which is 
81.2% of the total number of abnormally located glands and 12.9% of the 
total number of glands found. These 121 glands were found in 104 of our 
267 patients. Twelve of them had been referred to us after the failure of an 
exploration elsewhere, so that (in this respect aselectively) in ~~~~ X 
100 = 36.0% of the patients a mediastinally located gland was found. A 
percentage as high as this is not mentioned anywhere in the literature, and 
we shall therefore describe these findings in some detail. 
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Intra-thymic localization: Because of the local anatomical relationships, 
intrathymic glands always lie retrosternally in the anterior mediastinum. 
The level at which they lie can be indicated: we call glands situated 0-2 em 
under the upper edge of the sternal manubrium 'high intra-thymic'; those 
located 2-4 em lower are in an intermediate position; and those lying more 
than 4 em under the upper edge of the sternal manubrium are situated 'low' 
in the thymus (see Table VIII). 
Table VIII. Intra-thymic localization of parathyroid glands. 
No. of No. of 
Side patients Situation glands 
Right 20 High 46 
Left 25 Intermediate 20 
Bilateral 17 Low 13 
Total 62 79 
Table VIII shows that abnormal locations occurred almost as often on the 
left as on the right side. Of the 79 glands, 27 were normal and 52 enlarged. 
Four of the glands were found in patients who had already undergone 
62-4 
exploration elsewhere. Thus, in at least 
2 7 
x 100 = 22.1% of the pa-6 -4 
tients an intra-thymic location in the thymus was found aselectively. This 
percentage too is higher than any of those given in the literature. 
It can also be seen from Table VIII that the glands are not usually 
situated low in the thymus. Nevertheless, the possibility of a low intra-
thymic situation must be kept in mind and, if possible, the entire thymus 
should be dissected free to obtain certainty that a tumor is not left behind 
in the lower pole. 
In 12 patients in our series in whom we found more than 2 glands on one 
side, 5 of the surplus glands Jay in the thymus. The intra-thymic glands are 
always lower parathyroids. However, we have seen three cases of an 
anatomical variant in which an upper parathyroid gland was surrounded 
by ectopic thymus tissue. 
M ediastinallocalizations outside the thymus: All the glands we found outside 
the thymus in the mediastinum were enlarged. This holds for both the 
anterior and the posterior mediastinum. For these tumors, Table IX shows 
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the distance from the tumor to the upper edge of the sternum. We have 
already pointed out (page 10) that it may depend on the degree of extension 
of the neck whether or not the localization is retrosternal. The localizations 
given in Table IX represent the surgical findings made with the head fixed 
in slight extension. 
It seems to us important to indicate here too the level at which these 
glands were found, the more so because the depth of the localization 
is determinative for the recognition and the mode of excision. Tumors whose 
midpoint or upper margin reaches to the sternal notch are of course easily 
found through the cervical incision. From the anatomical standpoint, 
their situation is mediastinal. Tumors with a completely retrosternal 
position but located less than 5 em from the sternal notch can be found 
during the exploration of the thymus. When the position is still more 
caudal (which corresponds roughly to the level of the innominate artery), 
this is not possible. 
Table IX. Localization of mediastinal tumors in the present series. 
No. of tumors 
Localization anterior posterior 
mediastinum medias tin urn 
Midpoint of tumor on sternal notch 10 11 
Upper edge on stemal notch 7 5 
Less than 5 em under sternal notch 3 3 
More than 5 em under sternal notch 3 0 
Total 23 19 
·------
The glands found in the posterior mediastinum were always upper para-
thyroids; 16 were located on the right side, 3 on the left. Glands in the 
anterior mediastinum were always (like the intra-thymic glands) lower 
parathyroids: 12 on the right, 11 on the left. In our patients no normal glands 
were found in the mediastinum outside the thymus. Eight of these patients 
were re-explored by us after failures elsewhere: 5 cases concerned a tumor 
lying at the level of the sternal notch, in 2 it lay entirely retrostemally less 
than 5 em from the upper edge of the sternum, and in 1 case the tumor lay 
h 5 1 h A 1 . 1 h . 
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= 13.8% of the patients a tumor with a mediastinal location outside the 
thymus was found. 
Abnormal localizations in an extreme dorsal position: When such glands are 
normal and thus have small dimensions, they are sometimes difficult to find. 
When the possibility of this abnormal localization is kept in mind, however, 
tumors are only hard to locate at re-explorations hampered by heavy 
reactive formation of connective tissue. 
Table X. Abnormal, extreme dorsal situation of parathyroids in the present material. 
Localization 
Against the trachea 
Between trachea and esophagus 
Against the esophagus 
Behind the esophagus 
Total 
No. and type of gland 
2, both normal 
2, one normal, one tumor 
3, all tumors 
3, all tumors 
10, 3 normal, 7 tumors 
Nine of these glands were upper parathyroids; 4 lay on the right and 5 on 
the left. One paratracheally situated gland arose from the lower left para-
thyroid. 
Intra-thyroidal localizations: In 7 cases we found a tumor lying partially 
within and partially outside the capsule of the thyroid gland. For such 
glands, which like icebergs are partially concealed, care must be taken not 
to underestimate the size. 
In 9 patients we found 10 glands entirely within the capsule; one of these 
cases concerned bilateral glands, the one on right being normal, the one on 
the left enlarged. This patient had been referred for re-exploration. In an-
other patient a normal gland was found within the right lower lobe sur-
rounded by thyroid gland follicles. 
Thus, a total of 15 tumors and 2 normal parathyroids were found in the 
thyroid gland; there was no preferred localization. 
15-1 
Aselectively, in 
255_1 X 100 = 5.5% of the cases a completely or parti-
ally intra-thyroidal tumor was found. 
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Ante-thyroidal localization: This localization was seen only once in our 
material. The tumor lay on the anterior surface of the thyroid gland behind 
the sternothyroid muscle. Judged from the vascularization, this tumor had 
arisen from the lower right, but normal glands were also seen on the upper 
and lower right, which means that in this case there was not only an ab-
normal localization but also doubling of the gland. 
§ 2. ANALYSIS OF THE TECHNICAL RESULTS 
An exploration for hyperparathyroidism can only succeed when the diag-
nosis is correct and all the parathyroids are found. The latter is dependent 
on the localization of the tumors and on whether an unsuccessful explo-
ration has already taken place, since, as mentioned above, thiss everely 
hampers re-exploration. 
For the composition of our patient material, see Table III (page 41). 
The present material 
For the group of 236 patients seen first by us, the first exploration was 
successful in 223 cases. In 6 patients a cure could only be achieved by re-
exploration required because the tumors could not be found in their abnor-
mal situation at the first exploration (see Table XI). These failures belonged 
to the early part of the series, i.e. among the first 71 patients. With the 
accumulation of experience this no longer occurred, the more so because the 
lesson we drew from these failures led to improvement of the surgical 
technique. Of these 6 tumors, 3 lay intra-thymically, 2 retro-sternally, and 
one partially intra-thyroidally. 
Table XI. Surgical results in our own patients. 
Result 
Normocalcemia - after 1st expl. 
after re-expl. 
Persisting hypercalcemia, des-
pite removal of 4 or 5 tumors 
No enlarged parathyroids found 
Exploration to confirm diagnosis 
of essential hypercalcuria 
Erroneous diagnosis 
Pseudo-hyperparathyroidism 
Sarcoidosis 
Total 
no. of cases 
223 
6 
1 
3 
56 
% 
94.6 
2.5 
no. of cases 
229 
2 
0 
1 
4 
236 
% 
97.1 
0.8 
0.0 
0.4 
1.7 
100.0 
Thus, in the patients with a proven hyperparathyroidism, normocalcemia 
was achieved in 229 out of 231, or 99.1 %· In the other two patients enlarged 
parathyroids were found and removed (4 in one case and 5 in the other) but 
a slight hypercalcemia persisted and we must assume that a 5th and 6th 
enlarged parathyroid gland had been missed. 
Discussion of the 5 patients in whom no hyperparathyroidism could be demon-
strated. 
a. The patient was a 37 year old man with severe hypercalcuria and a severe kidney 
disease with uremia. Clinically, the diagnosis essential hypercalcuria seemed 
certain, but because of the severely impaired kidney function it was thought 
desirable to obtain absolute certainty by an exploration of the parathyroids. At 
the exploration in 1962, four normal parathyroids were found, so that the diagnosis 
idiopathic hypercalcuria could be confirmed. In his article entitled Vicissitudes 
of parathyroid surgery (1961), Cope gives an excellent discussion of these problem-
atical cases. 
b. A 57 year old female patient had the typical biochemical anomalies found in 
hyperparathyroidism. The function of the left kidney was entirely normal, and it 
was known that the right kidney had not functioned for 10 years; consequently, 
this was not further investigated. At neck dissection, no enlarged parathyroids 
were found, only 3 normal glands. A re-exploration was considered, but the 
patient rapidly developed symptoms of cerebral metastases and she died shortly 
thereafter of a primary carcinoma in the non-functioning kidney. It is known that 
renal cell carcinoma can produce a substance resembling parathyroid hormone, 
giving rise to pseudo-hyperparathyroidism. 
c. In three cases hypercalcemia was caused by sarcoidosis that had not been recog-
nized pre-operatively in spite of a thorough investigation of the internal organs. 
In one of these cases the Mantoux reaction was positive and the hypercalcemia did 
not respond to the administration of cortisone. The second patient had had a 
concomittant renal insufficiency, which complicated the diagnosis. In all three 
patients the diagnosis was suspected during the operation because of the presence 
of normal parathyroids and numerous pea-sized glands along the recurrent nerve. 
Histological examination of frozen sections of these lymph glands led to the correct 
diagnosis. In one of these patients a the typical sarcoid granuloma was found in the 
biopsy sample taken from one of the parathyroid glands (see also page 71). 
In 2 patients the hypercalcemia persisted in spite of the removal of several 
enlarged parathyroid glands. 
a. A 54 year old woman in whom a subtotal parathyroidectomy was performed be-
cause of enlargement of all four glands, continued to show hypercalcemia post-
operatively. In this case there were probably more than four tumors, but the 
patient refused re-exploration. 
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b. A 53 year old man had a plasma [Ca] of 14.7-15.5 mg/100 mi. At exploration 
5 tumors were found, and a subtotal parathyroidectomy was performed. Post-
operatively, the plasma [Ca] dropped only to 11.6-13-2 mgf100ml. Further surgical 
treatment was not attempted. This probably concerned a case with 6 tumors. 
Re-explorations in patients previously operated on elsewhere 
In 24 of the 31 patients referred to us from other hospitals for re-exploration 
we were able to find the tumors (see Table XII). 
Table XII. Results of 31 re-explorations of patients previously explored elsewhere. 
Results No. of patients % 
Successful - normal localization 11 35 
Successful - abnormal localization 13 42 
Failure 5 23 
Failure (tumor already removed elsewhere) 2 
Total 31 100 
We made an attempt to determine what the reason could have been for the 
failure elsewhere to find the tumor. For the 11 patients in whom the tumors 
lay in the normal area, we assume that, in view of our findings, the thyroid 
gland had been insufficiently mobilized in one case, in 2 cases frozen sections 
had not been used, resulting in the removal of thyroid tissue; and in the 
other cases the tumor must simply have been missed. 
In 13 patients an abnormal localization was involved: in 4 the tumor lay 
in the thymus, in 5 at the level of the edge of the sternal notch, in the 
posterior mediastinum. In 2 cases the tumors Ia y 2 em and 3 em from the 
sternal notch. In 1, a sternotomy had to be performed because the tumor lay 
at the level of the pulmonary hilus. One patient had a partially intra-
thyroidal tumor. 
In 7 patients we too failed to find a tumor. In 2 of these an enlarged 
parathyroid had been removed elsewhere but the hypercalcemia had 
persisted. Twice, the failure was due to a very tough fibrosis in the surgical 
field, which made the re-exploration impossible. One patient, in whom 
glands weighing 50, 80, and 100 mg were excised and a normal gland was 
left in situ, developed cardiac arrest post-operatively, but external heart 
massage was successful. This patient remained hypercalcemic, but further 
surgery was not undertaken because of the cardiac condition. In 1 patient 
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cardiac arrest occurred during the exploration. After re-animation, we 
refrained from further surgery. In the remaining 3 patients the ana-
tomical relationships were so disturbed by previous operations (especially 
after total thyroidectomy) that no tumors could be found. 
§ 3. THE FINDINGS IN 255 PATIENTS WITH PROVEN PRIMARY HYPER-
PARATHYROIDISM 
Among our own patients, at least one tumor (i.e. enlarged gland) was found 
in 229 cases. In 24 of the 31 patients who had undergone exploration else-
where, the surgical results were also positive; a tumor had previously been 
removed in two of the other 7 cases. In total, these groups include 255 
patients with a proven primary hyperparathyroidism. 
The origin of the tumors 
Figs. 4 and 5 give a schematic survey showing from which glands the tumors 
in our material originated. The often cited statement of Norris (1947) that 
80% of the tumors originate in the lower right parathyroid gland, is certainly 
not correct. His conclusion is probably to be explained by the following. 
Explorations are almost always started on the right side. Formerly, oper-
ations were terminated after a tumor had been found, which made it in-
evitable that tumors on the right side would be found most frequently. The 
predominance of the lower gland may result from an erroneous observation: 
the tumors arising from the upper glands tend to descend caudally and 
may there for be taken for the lower glands. As can be seen from Fig. 4, 
in our material too solitary tumors were found more often on the lower right. 
It is also clear from Figs. 4 and 5 that the origin of the tumors varies so 
widely that such data are irrelevant with respect to the surgical method. 
To insure success, all the glands must be exposed. 
The number of tumors 
Table XIII shows how many tumors were found per patient. The values 
between parentheses indicate the number of patients in whom only enlarged 
and no normal glands were found, possibly because the exploration was not 
sufficiently thorough or because at an earlier exploration or thyroidectomy 
parathyroid glands had been removed by mistake (see also Figs. 4 and 5). 
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on one side 
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Table XIII. The number of tumors per patient in our material. 
No. of tumors No. of patients 
1 146 (14)* 
2 41 ( 3) 
3 21 ( 7) 
4 45 (42) 
5 2 ( 2) 
Total 255 (68) 
* Between parentheses: only enlarged glands found. 
% 
57.3 
16.1 
8.2 
17.6 
0.8 
100.0 
In 41 patients all 4 glands were found to be enlarged and in 2 all 5, i.e. in 
41 + 2 . . 
255 
X 100 = 16.8% of the patients all the glands were certamly enlarged. 
It is theoretically possible that enlargement of all the glands was present 
in 68 x 100 = 26.6% of the patients. 
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To permit comparison of our findings with those of other authors, our 
data must be subdivided in another way. Cases in which we found two or 
three tumors would be called mnltiple adenoma by most other authors. For 
enlargement of all glands, comparison can be made with primary hyperplasia 
(see page 20). 
Table XIV. Comparison of our numerical findings with the data in the literature. 
Literature % Our series % 
Solitary adenoma 70-88 One tumor 52.7 
Multiple adenoma 0.1-6 More than one tumor 23.5 
Primary hyperplasia 11-25 All tumors 16.8-(26.6) 
As has already been mentioned, in the literature the diagnosis multiple 
adenoma is reported less and less often and the diagnosis primary hyper-
plasia more and more often. The latter is confirmed by our findings. There 
is, however, considerable divergence between the number of multiple tumors, 
plus at least one gland of normal size, found by us and the reported number 
of multiple adenomata in the literature (see Table XIV). There are two 
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possible reasons for this divergence. Firstly, we consistently tried to find all 
the parathyroids and therefore found more tumors. The second an din our opi-
nion the most important reason, is that we took as sole basis the macroscopic 
appearance of the glands. We are therefore forced to conclude that not only 
the cases with enlargement of all glands observed by us but also those with 
enlargement of several glands plus at least one gland of normal size represent 
the picture called primary chief cell hyperplasia by others. Regarded in this 
way, our values show better agreement with those of Paloyan et al. (1969), 
i.e. 58% primary hyperplasias. Particularly the findings in 19 patients with 
three and four tumors plus one normal-sized gland support the view that in 
what is called primary chief cell hyperplasia all the glands do not per 
definition have to be enlarged. 
The difficulties and limitations involved in the diagnosis normal or hyper-
plasia on the basis of the histological picture has already been discussed 
(see page 20 ff.). 
The validity of our grounds for a practical approach, i.e. macroscopically 
normal = functionally normal, and for the theoretical approach, i.e. macro-
scopically normal = microscopically normal = functionally normal, can in 
our opinion only be investigated at present on the basis of the number of 
recurrences of primary hyperparathyroidism developing in our patients in 
glands that had previously been macroscopically normal. 
§ 4. RESECTION OF THE TUMORS 
The excision of normally and subnormally situated glands generally did not 
give any difficulties. In two cases the tumor adhered to the recurrent 
laryngeal nerve but could be dissected free without damage to the nerve. 
In one case the tumor adhered to the posterior wall of the esophagus and 
even lay partially within the muscular layer. 
Glands situated intra-thymically and those found less than 5 em from the 
sternal notch could always be resected through the neck incision, although 
this sometimes required extra effort. 
Sternotomy: This was necessary in three patients, in all of whom the tumor 
was situated below the level of the innominate artery: twice at the level of 
the pulmonary hilus, once near the origin of the aorta. Thus, the necessity 
3 . 
for a sternotomy occurred in 
255 = 1.2% of our patients. 
For purposes of comparison, we wish to note that in the literature a 
mediastinal tumor is mentioned for at most 21% of the patients, at least 
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1.7% requiring a sternotomy. In our series these values are 36% and 1.2% 
respectively. In view of the high proportion of mediastinal tumors it is 
very obvious that retrosternal exploration through the cervical incision is 
an extremely valuable procedure in parathyroid surgery. 
In 6 cases we performed a sternotomy without finding glands. In 5 of 
these patients the tumor was nevertheless found in the neck at a later stage. 
In one patient we failed to find a tumor either during the neck exploration 
or at sternotomy; post-operatively, the hypercalcemia persisted, so that 
this case must be considered one of our failures. 
Intra-thyroidally situated glands: Fourteen of the tumors were found at 
inspection and palpation of the thyroid gland. After ligation of the inferior 
thyroid artery and incision of the capsule, they could be removed with ease. 
In one patient after a right hemithyroidectomy a normal gland was found 
in the resected specimen. In another patient a bilateral resection of the lower 
lobe was performed, the indication being absence of both lower parathyroids, 
a small multinodular thyroid (and therefore not easy to palpate), and a 
suspicious brown discoloration of the left lower pole for which the biopsy 
sample provided no information (no parathyroid tissue was present). Later 
investigation showed a normal parathyroid gland in the lower right part of 
the specimen and on the left, in the suspected area, an enlarged parathyroid 
was found. The biopsy had unfortunately been inadequate. 
In 5 cases a hemithyroidectomy and in 1 case a subtotal thyroidectomy 
were performed without success. 
From the foregoing the great value of inspection and palpation of the 
thyroid gland is clear. Intra-thyroidally situated tumors are relatively easy 
to locate. Normal glands cannot be found in this way, but their resection 
has no clinical value. In multinodular thyroids, thyroidotomy and possibly 
lobe resection must be considered indicated when intra-thyroidal tumors 
are suspected. 
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Chapter X - Post-operative course 
Of the 255 patients in whom parathyroid tumors were removed, 187 (73.4%) 
could be followed over a period averaging 3! years (see Fig. 6). 
No. of 
patients 
years 
Fig. 6. Follow-up period after parathyroidectomy in the present series. 
We consider a parathyroid exploration successful when the biochemical 
changes that are the direct result of the abnormally high plasma [PTHJ 
are permanently normalized by the surgical treatment (albeit sometimes 
with a post-operative hypocalcemic phase due to calcium hunger of the 
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bone). The results of the exploration in 260 patients in whom the diagnosis 
was confirmed clinically and biochemically, are shown in Table XV. 
Table XV. Surgical results in 260 patients of the present series. 
Euparathyroidism 
Hypercalcemia - no tumor found 
Hypercalcemia- despite removal of tumor(s) 
Possible recurrence* 
Aparathyroidism* 
No. of patients 
240 
5 
6 
7 
3 
% 
92.4 
1.9 
2.3 
2.7 
1.2 
* One patient became aparathyroitic due to re-exploration for a possible recurrence. 
Thus, in 20 patients (7.6%) the expected result was not reached, because of 
either inadequate or excessive resection. Cope (1960) considered resection 
to have been inadequate in 20% and Hellstrom and Ivemark (1962) in 18% 
of their patients. Experience led these authors to point out that improve-
ment of the results occurs especially when all the glands are inspected at the 
operation. 
That our results compare so favorably is to be attributed to the fact that 
almost from the beginning of the present series we have attempted to inspect 
all the parathyroids. The data and results of Davies (1966) run consistently 
parallel with ours. Comparison between our results and those of Black (1952, 
1963) is impossible because of lack of data. Lastly, it may also be remarked 
that in our 20 cases of failure, improvement of the biochemical anomalies 
was nevertheless attained in 15 (i.e. reduction of the hypercalcemia, albeit 
not to normal values), because the amount of tumor tissue was reduced. 
Post-operative plasma [Ca] 
In all those patients in whom the exploration was successful, the plasma 
[Ca] dropped to the norm within 1 to 7 days (average 2 to 3 days). 
Fourty-four patients showed a transient hypocalcemia below 8.5 mg/100 ml 
(Wade et al. 1965•,b, Fourman et al. 1969), often accompanied by clinical 
phenomena such as paresthesia and Chvostek' s sign. The severity of this 
hypocalcemia is also dependent on the degree of bone decalcification and 
elevation of the alkaline phosphatase level (Howard & Thomas 1963) and 
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the quantity of residual functional parathyroid tissue. Most of these patients 
were given calcium orally or parentally for some time and some received 
dihydrotachysterol orally. 
In patients in whom the operation failed or the tumors were not found at 
the first exploration, the plasma [Ca] did not drop to normal values post-
operatively in any of the cases. 
These findings have led us to conclude that repeated determination of the 
plasma [Ca J during the first week after the operation gives a reliable, easily 
and rapidly obtainable impression of the surgical results. 
Complications 
As a direct result of the operation, the following complications occurred 
among 267 patients. In one patient the common carotid artery tore, for 
which a Teflon prosthesis was placed around the artery. In another patient 
a small tear in the thyrocervical artery was sutured. In one case a small 
hemorrhage occurred post-operatively. 
Damage to the recurrent laryngeal nerve rarely occurred (cf. Baehrs & 
Vander Toll 1963). We ascribe this to our rule that the nerve must be 
fully exposed before closer inspection is begun. Only one patient in this 
series has a permanent unilateral paralysis of the vocal cord. One other 
patient had a unilateral paresis for three months after the operation, but 
this patient had been intubated for 24 hours. 
All the above-described complications occurred in patients in whom 
fibrosis and disturbance of the normal anatomical relationships obscured 
the surgical field, and all these patients had already undergone two ex-
plorations. 
In two patients pneumothorax developed after sternotomy, but this never 
occurred after exploration of the mediastinum through the cervical incision, 
in contrast to the report of Nathaniels et al. (1970). 
Complications possibly related to hyperparathyroidism but probably not 
to the exploration itself, were encountered in two patients who later died. 
One of these patients probably died from a hypercalcemic crisis. One 
of the 31 patients referred to us for re-exploration died a month after 
an unsuccessful re-exploration for a possible recurrence of primary hyper-
parathyroidism. The cause of death was Zollinger-Ellison's syndrome, for 
which he had undergone several operations. One patient, who had al-
ready vomited on the day before the operation, developed an acute pan-
creatitis on the first post-operative day (confirmed by laparotomy). 
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Other complications seen by us were 2 cases of an obstructive pneumonia 
aud 5 cases of cardiac arhythmia, including 2 patients with cardiac arrest, 
both of whom were successfully re-animated. 
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Mortality 
Chapter XI The prognosis 
of primary hyperparathyroidism 
The final course of the disease is dependent on a combination of factors 
including the severity of the secondary damage and the degree of surgical 
success achieved, both of which are in turn dependent on the nature of the 
tumor (Lloyd 1968). The pre-operative condition of the kidneys is by far 
the most important factor with respect to the prognosis. Renal hypertension 
does not as a rule improve post-operatively, and is the most frequent cause 
of death in cases of late diagnosis. Hellstrom and lvemark (1962) mention a 
mortality of 9% due to renal insufficienty after successful parathyroid 
operations. Poor kidney function improves post-operatively in about 10% 
of the cases (Hellstrom 1953, 1965). Nephrocalcinosis does not show re-
gression, but after parathyroidectomy the frequency of recurrent urolithiasis 
decreases by about 70% (Bradshaw et al. 1964, McGeown 1965). Gastro-
intestinal and mental disturbances may, if caused by hyperparathyroidism, 
show considerable improvement (Hellstrom & I vemark 1962, Goldsmith 
et al. 1966). Bone anomalies almost always show functional recovery, but 
remain radiologically demonstrable (Bartlett & Cochran 1964). These 
aspects will not be gone into in detail here. We wish to mention, however, 
that only two of our patients succumbed to the effect of primary hyperpara-
thyroidism. One of these patients died two days after the operation as the 
result of a hypercalcemic crisis. 
This case concerned a 65 year old apathetic woman with a plasma [Ca] of 15.6-17.3 
mgjlOO ml. and a urea clearance of 11%- VVhile in the hospital she became increasing-
ly somnolent and an emergency transfer was arranged for an exploratory operation. 
Six hours before the time scheduled for the operation, hypotension developed and she 
became comatous. The hypotension \Vas corrected with noradrenalin. At surgery 
both enlarged upper parathyroids were removed. In view of the patient's condition a 
prolonged search for the lower glands was not made, but a tumor was not observed. 
Post-operatively, the plasma [Ca] dropped rapidly to 12.3 mg/100 ml. The patient 
vomitted old blood and became comatous again. She died 50 hours after the operation. 
Permission for an autopsy was not obtained. 
This may certainly be considered to have been a case of a hypercalcemic crisis due 
to 'PTH intoxication', also called parathyroid crisis. 
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Formerly, the mortality associated with this crisis was 20% when surgical 
treatment was applied and 100% when no operation was performed (Chodack 
et al. 1965; Wilson et al. 1964). At present it is known that these crises can 
often be avoided by forced hydration (MacLeod & Holloway 1967, Mannix 
& Loehr 1968). If the plasma [Ca] rises nevertheless or the symptoms 
increase in severity, a decrease in the plasma [Ca] must be induced by the 
infusion of phosphate (Goldsmith & Ingbar 1966, Gardner & Koppel1969). 
Our second patient died one year after the operation in a uremic condition 
due to poor kidney function, from which she had already suffered before the 
operation. 
The low mortality in our series can only be ascribed to the fact that in 
our- patients the diagnosis primary hyperparathyroidism had been made in 
an early stage by the urologists and internists to whom they had been referred. 
Three other patients in this series died of diseases not known to have any 
relationship with primary hyperparathyroidism: plasmocytoma, mammary 
carcinoma, and pulmonary emphysema with cor pulmonale (see Fig. 6). 
Recurrence 
As already mentioned, the study of recurrence of primary hyperparathyroid-
ism is of paramount importance for an understanding of the pathogenesis 
of the disease and for the evaluation of our point of view concerning the 
removal of grossly normal glands. In the literature recurrences are mentioned 
only incidentally or as casuistic information; essential data about the course 
of the process are often omitted. We have already discussed the reports of 
Paloyan et al. (1969) (page 46). 
The term 1recurrence' is often used in the literature - in our opinion in-
correctly- for cases in which it is not clear whether there had been enlarge-
ment of glands previously observed to be normal or .whether the operation 
had been only partially successful because not all the tumors had been 
removed. In the latter case we prefer to use the term false recurrence. In 
our opinion a true recurrence is involved only when the following criteria 
are satisfied. A successful operation is followed by a period of nonnocalcemia. 
Subsequently, there is a clinical and/or biochemical recurrence of hyper-
parathyroidism as a result of growth of the previously macroscopically 
normal gland(s) found and biopsied at an earlier exploration. Furthermore, 
indications of a prior secondary hyperparathyroidism must be absent (e.g. 
in osteomalacia or poor renal function). We will discuss the case histories 
of our patients with recurrences and attempt to differentiate between true 
and false recurrences. All of the 7 patients with recurrences belong to the 
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group of 229 patients in whom the exploration was successful and who were 
referred to us without previous surgical treatment, i.e. there were 2~9 x 100 
= 3.1% recurrences. 
1. A woman of 60 years (1955). Three enlarged parathyroid glands (250, 500, and 
600 mg), all showing almost exclusively chief cells, were removed. The fourth 
gland was grossly normal, but no biopsy samples were taken to confirm the diagnosis 
parathyroid tissue. The plasma [Ca] of 15.2 dropped to 10.9 mg% post-
operatively. 
In 1964, plasma [Ca] was 9.8 mg% with a hypercalcuria of 293-382 mg/24 hr 
while the patient was on a Snapper diet; the creatinin clearance was 107 ml per 
minute. In 1967 the plasma [Ca] was 11.2-13.0 mg%; the patient complained of 
gastric pain. In 1968 plasma [Ca] of 10.5-10.7 mg% were found. No other data 
are available. 
Since it is not certain that the fourth gland was normal and because the 
plasma [Ca] did not normalize post-operatively, we judge this to be a 
question of persisting hyperparathyroidism - albeit to a lower degree -
in other words a false recurrence. It is quite possible that the findings in 
1964 were related to a normocalcemic primary hyperparathyroidism. 
2. A woman of 39 years (1956). A tumor weighing 100 mg and composed of water-
clear cells was removed. Biopsy samples were taken from two other glands having 
a normal appearance; the fourth gland was not seen. Post-operatively, the plasma 
[Ca] dropped to 9.9 mg% and then rose within a week to 10.8 mg%. From then 
until 1962, high-normal blood levels of calcium were found. In 1965 the plasma 
[Ca] was 11.7 mg% and plasma creatinine 0.83 mg%. In 1970 there was a hyper-
calcemia of 11.0 mg%. 
On the basis of the post-operative rise of the plasma [Ca] above normal 
and the variable hypercalcemia after 1965, we consider this to be a false 
recurrence. 
3. A man of 32 years (1963). Two parathyroid tumors located at the lower poles of 
the thyroid gland and each weighing 300 mg were removed; both were composed of 
water-clear cells. No other parathyroid glands were observed. Post-operatively, 
the plasma [Ca] dropped to 9.4 mg% and then rose spontaneously to 10.1 mg%. 
In 1965 the patient had recurrent complaints of a gastric ulcer. The plasma [Ca] 
was 10.5-10.9 mg%, the creatinine clearance was 111 mlfmin. There-exploration 
showed that in 1963 not the lower but the upper parathyroids had been removed. 
The lower glands lay intra-thymically and were estimated to weigh 750 and 300 
mg. The larger tumor was totally resected, the smaller one subtotally. These 
70 
tumors too were composed of water-clear cells. Post-operatively, a brief period of 
hypocalcemia was observed, for which 2 g calcium daily was given orally. There-
after, the patient remained normocalcemic. 
This case too did not satisfy the criteria justifying a diagnosis of true 
recurrence. Unfortunately, it is not known how long after the first operation 
hypercalcemia recurred. In any case, the interval between the two explo-
rations was short (two years). 
4. A woman of 47 years (1955). A tumor weighing 2,250 mg and composed of chief 
cells was removed; the three other glands appeared normal and biopsy samples were 
taken. Normocalcernia developed post-operatively. In 1963, hypercalcemia 
(11.4-12.5 mg%) and a hypercalcuria (333 mg/24 hr) vvere found. The creatinine 
clearance amounted to only 22-27 mlfmin. At re-exploration, both upper parathy-
roid glands were found to be enlarged (estimated weight 150 mg), and were totally 
resected. The remaining gland was not found. Post-operatively, the hypercalcemia 
persisted at the same level, and another re-exploration was performed. Pathological 
lymphomas were now found in the mediastinum, the histological picture being 
consistent with sarcoidosis. Normocalcemia could then be achieved with cortico-
steroid therapy, which was still applied with success in 1970. 
This was certainly not a case of true recurrence. In view of the persisting 
hypercalcemia after the first re-exploration, we consider tertiary hyper-
parathyroidism to be excluded as well. The enlargement of the two 
glands seen at the second operation may have been the result of the bad 
kidney function. On the basis of the good response to corticosteroid therapy, 
the hypercalcemia must be ascribed to the sarcoidosis, which developed in a 
patient in whom a successful parathyroid exploration had been performed 
in the first instance (1955). 
5. A woman of 59 years (1957). A tumor weighing 1,500 mg and composed mainly of 
chief cells but also showing groups of water-clear cells, was removed; no other 
glands were found. Post-operatively, the plasma [Ca] dropped to 9.0 mg% and 
then rose during her stay in the hospital to 10.4 mg%. In 1960 and 1961 these 
values were 10.8 and 10.4, respectively. In 1966 values of 10.8-11.2 mg% were 
found, in 1967 and 1970, 11.1 and 10.6 mg%, respectively. Since the patient had 
no complaints and the kidney function was very good, further evaluation was 
omitted. 
Here, too, we consider that a false recurrence was involved, because the 
calcium level was consistently rather high post-operatively and only one 
gland had been found at exploration. 
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6. A woman of 54 years {1961). Two tumors composed of water-clear cells were 
removed, both weighing 400 mg. The lower parathyroids were not seen. Normo-
calcemia developed post-operatively and persisted until 1963. The next determi-
nation was not made until 1968, when the patient returned because of her old 
complaint, a duodenal ulcer. The plasma [Ca] was 12.4-13.6 mg% and kidney 
function was good, as prior to the first operation. At re-exploration the lower 
parathyroids were found bilaterally in the thymus and were removed. One was of 
normal size, the other weighed 800 mg and was composed of water-clear cells. 
Post-operatively, a severe hypocalcemia developed due to the surgically acquired 
aparathyroidism. Substitution therapy with calcium and dihydrotachysterol led 
to normocalcemia in 1969. 
In this case too, we do not consider that a true recurrence was demonstrated, 
because at the first operation only two glands had been seen. 
7. A woman of 45 years (1960). Two parathyroids weighing 800 and 200 mg and 
composed of chief and transitional water-clear cells were removed. The other two 
parathyroids were considered normal but not biopsied. Post-operatively, the 
plasma [Ca] dropped to 9.5 mg%; in 1961, 1962, and 1963 the values were 10.4, 
10.5, and 10.2 mg%, respectively, the plasma [P04 ] varying from 2.0 tot 2.6 mg%. 
In 1966 hypertension was found and a chlorthiazide preparation was administered, 
resulting in a hypercalcemia of 11.3 mg% and a plasma [P04] of 2.0 mg%. After 
termination of this anti-hypertension therapy the plasma [Ca] was 10.5 mg%, the 
plasma [PO 4 ] 1.9 mg%. In 1970 a spontaneous, very slight hypercalcemia of 
10.8-10.9 mg% and a plasma [P0 4 ] of 1.8-2.0 mg% were found. Clinical analysis 
showed a slight hypercalcuria (179-204 mg/24 hr) with the patient on a Snapper 
diet. Radiologically, a slight decalcification of the bones of the skull was de-
monstrated. The histological results in a bone biopsy sample were consistent with 
hyperparathyroidism. The intravenous pyelogram showed a kidney stone not 
previously observed. The patient still has no complaints suggesting primary 
hyperparathyroidism. However, since a kidney stone had been demonstrated a 
re-exploration was undertaken in 1971. No tumor or normal glands could be found. 
This last case is the only one in our series in which the possibility of the 
existence of a true recurrence cannot be denied. However, no biopsy 
samples were taken from the normal glands at the first operation and re-
exploration failed to show whether enlargement of any of the previously 
normal glands had occurred or an ectopic, enlarged fifth gland was present, 
s;nce no glands could be found. 
It is clear that, in contradiction with the reports in the literature, true 
recurrence must be very rare. False recurrence due to inadequate explo-
ration occurs more frequently. 
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A parathyroid ism 
In three patients all four parathyroid glands were erroneously removed. We 
consider this to be a severe mutilation of the endocrine system, even though 
all these patients were cured of hyperparathyroidism. Although apara-
thyroidism can be compensated for by substitution therapy, it may be 
difficult to arrive at, and maintain the desired normocalcemia. In a sense the 
situation is comparable to that of a diabetic who requires treatment with 
insulin throughout life. 
We have already described above (Case 6) the way in which one of our patients be-
came aparathyroidic due to the treatment of a (probably false) recurrence. At this 
re-exploration the remaining two glands were found in the thymus. The error which 
was then made was that, in divergence from our principle, the resection of the found 
(normal) gland was performed before the heterolateral side was explored. At that 
moment we failed to realize that with the resection of this tumor all the possibly 
present parathyroid tissue would be removed. If we had realized this, subtotal re-
section might have offered a solution. 
The second patient was re-explored after two normal parathyroids had been re-
moved and a 'blind' subtotal thyroidectomy and a bilateral thymectomy had been 
performed at two operations done elsewhere. At re-exploration we found a partially 
retrosternally located tumor which in view of the vascularization must have developed 
in the left upper parathyroid. This 15-g tumor was totally resected, after which the 
plasma [Ca] dropped to 6.7 mg%. At present, seven years after the last operation, 
substitution therapy is still required. 
The third patient had undergone a subtotal thyroidectomy 10 years before the 
parathyroid exploration. At operation a small remnant of the thyroid gland proved 
to be still present. On the lower right side a parathyroid tumor weighing 600 mg was 
resected, after which a hypocalcemia of 7.6 mg/100 ml developed. At present, seven 
years after the operation, the patient is still receiving substitution therapy. 
We are of the opinion that in all these patients no functioning parathyroid 
tissue and therefore no circulating PTH are present. For this condition we 
have introduced the term aparathyroidism. 
In the first patient this situation could have been avoided. In the patients 
treated elsewhere with radical surgery we would have done better to resect 
the tumor subtotally instead of totally. In two other patients in whom there 
was an analagous situation, in one case we implanted a small piece of the 
tumor, with preservation of the vascular pedicle, in the sternocleidomastoid 
muscle and removed the rest of the tumor, which resulted post-operatively 
in permanent normocalcemia, and in the other case the tumor was completely 
resected. In the latter case fortune favored the patient: post-operatively, 
a persisting normocalcemia developed spontaneously, indicating that un-
observed and functioning parathyroid tissue must have been present. 
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Preventive subtotal parathyroidectomy 
Because primary hyperplasia is being diagnosed histologically with in-
creasing frequency in both normal-sized and enlarged parathyroid glands, 
a preventive subtotal parathyroidectomy was perlormed in 11 patients in 
our series without regard to the local findings. The macroscopically enlarged 
and sometimes normal glands were removed in the hope of reducing the 
number of future recurrences. An estimated 15 to 60 mg (average 30 mg) 
parathyroid tissue belonging to one or two glands with the least enlarge-
ment or most normal appearance was left in place. In 3 of the 11 patients no 
hypocalcemia developed after the successful operation. Five of the patients 
showed a slight hypocalcemia that responded to the administration of 
supplementary calcium for one week to two mouths after the operation. 
Three patients iu whom there could be no question of severe calcium 
deficiency of the bone or of aparathyroidism (30-35 mg parathyroid tissue 
belonging to two glands had been left in place), developed a severe hypo-
calcemia post-operatively, which required correction with calcium and 
vitamin D preparations in spite of the risk involved in this treatment. In 
one of these patients this substitution therapy is still required at present, 
three years after the operation; for one of the others the duration of substi-
tution is not known to us, and the third required substitution for a period 
of two years. 
We have attempted to determine the degree to which the removal of 
normal parathyroid glands influences the post-operative calcium pattern. 
In the presence of severe deficiency in the bone, hypocalcemia of course 
always develops. We have been unable to demonstrate any correlation 
between the duration and severity of the hypocalcemia on the one hand and 
the amount of parathyroid tissue left in place on the other. The extent to 
which a possible overproduction of calcitonin is of influence here is not 
known. 
Concerning the chances of prevention of a recurrence of hyperparathyroid-
ism by this approach, we are unable to give a conclusive opinion after such 
a short period. It may be said, however, that in view of the fact that we 
have seen a (false) recurrence in only 3.1% of our patients and that this was 
mainly due to inadequate exploration, we consider that, under the condition 
that all the glands are inspected, little value is to be attached to the preven-
tive subtotal parathyroidectomy. The high incidence of severe hypopara-
thyroidism (37%) after this treatment seems to us to constitute an even 
stronger argument for not removing macroscopically entirely normal glands. 
The possibility of a post-operative hypoparathyroidism must always be 
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taken into account. It does not seem premature to assume on the basis of 
the present results that after a successful parathyroid exploration a pro-
longed asymptomatic hypocalcemia can develop, but no data on this point 
are available in the literature. The occurrence of asymptomatic hypopara-
thyroidism after thyroidectomy is known. In tetany the diagnosis hypo-
calcemia is not difficult. But the less overt forms of hypocalcemia and 
sometimes hypomagnesemia due to hypoparathyroidism are harder to 
distinguish. The symptomatology is highly variable, ranging from anxiety, 
depression, suicidal tendencies, and exogenic psychoses (Holtz 1932, 1934, 
Flink 1956, Fourman 1967, Anderson 1968, Newton & Summich 1968) to 
ill-defined manifestations of neuromuscular hyperexitability such as 
intestinal cramps and epileptic insults. Other findings are eczema, cataract, 
calcification of the basal ganglia, and papiledema due to elevated intra-
cranial pressure (Kyle et al. 1954, Dimich et al. 1967). These symptoms are 
described in hypoparathyroidism after thyroidectomy, but they are equally 
likely to occur after deliberate parathyroidectomy. No cases of this kind 
were found in our material. In a few patients, however, we did see de-
pressions -sometimes several months after the operation -but because the 
possibility of hypocalcemia was not taken into account, no determination of 
the plasma [Ca] was made. These pictures must certainly be kept in mind 
in connection with the post-operative care of our patients. The same 
actually applies to any patient with the scar of a collar incision on the neck. 
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Chapter XII - Summary and conclusions 
In the present work the data concerning 267 patients in whom a parathyroid 
gland exploration was performed are analysed. The diagnosis primary 
hyperparathyroidism was confirmed histologically in 255 of these cases. 
The number of normal parathyroid glands and their localizations are 
described on the basis of the data reported in the literature, from which 
our findings show little divergence. When a thorough exploration is 
performed, four glands are usually found, the frequency increasing with the 
accumulation of experience. To obtain good surgical results it is necessary, 
however, to take into account the fact that in 3 to 6% of the cases a total 
of more than four glands, or more than two glands on one side, are present. 
The localization of the normal glands is indicated: the upper parathyroids 
are usually situated against the posterior surface of the thyroid gland at the 
level of the cricoid cartilage, the lower parathyroids usually on the lower 
poles of the thyroid gland. Enlarged glands lie almost as often in the normal 
area as the normal glands. Tumors of the upper parathyroid glands in 
particular seem able to migrate caudally and dorsally over a considerable 
distance, even as far as the posterior mediastinum. Lastly, the difficulties 
and limitations involved in locating a parathyroid tumor via the vascular 
pedicle arising from the inferior thyroid artery are indicated. 
The importance and functional activity of the various types of cell found 
in the parathyroid gland (chief, transitional, water-clear, and oxyphil cells) 
are not yet known. The composition of the parenchyme varies widely with 
the age and the activity of the parathyroid gland. The normal picture for a 
given age must be known before the histological distinction between normal 
and pathological glands can be made. 
A brief discussion of the physiology of the parathyroid hormone and 
calcitonin is followed by a description of the pathological aspects of the 
abnormal gland. During the past ten years, solitary adenoma has been 
diagnosed somewhat less frequently and primary chief cell hyperplasia 
increasingly often. Multiple adenomata and primary water-clear cell hyper-
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plasia are seldom found at present. However, analysis of the criteria applied 
for the various pictures shows that the absolute criteria formerly employed 
for the distinction between these pictures have been used less and less often 
in recent years. For instance, the rim of normal tissue is found not only in 
adenomata but also in hyperplastic glands. Furthermore, a normal gland 
may be found not only in cases of adenoma but also in primary hyperplasia. 
The differentiation between adenomata and hyperplasia is therefore almost 
impossible to make and, even worse, the difference between pathological 
and normal tissue cannot be demonstrated in more than a few cases. For 
the surgeon, however, the histological investigation in conjunction with the 
operation is indispensable to avoid confusion between thyroid, parathyroid, 
thymic, and lymphatic tissue. 
The problem of the pathogenesis of primary hyperparathyroidism is domi-
nated by two main points. First, the only known stimulus for the para-
thyroid gland is hypocalcemia. Second, in hypercalcemia we find hyperplastic 
glands that histologically appear to lack an autonomous function. A 
theoretical explanation for this phenomenon is sought. Since tertiary 
hyperparathyroidism is repeatedly described, an attempt was made to 
identify a phase of (limited) hypocalcemia due to other than external causes 
in primary hyperparathyroidism as well. Affections of the thyroid gland 
appear to be found with surprising frequency as concomittant diseases, but 
it is not clear to what extent there is a causal relationship between thyroid 
disease and hyperparathyroidism. Hypercalcitoninism, acromegaly, hyper-
glucagonemia, and pancreatitis, may give rise to secondary and tertiary 
hyperparathyroidism. Seen in this light, the autonomous hyperparathy-
roidism seen in multiple endocrine adenomatosis could possibly be tertiary, 
although in the latter disease and in hyperparathyroidism, if only on the 
basis of the familial occurrence of both, the possibility of a genetic error 
must be taken into account. 
The parallel between the more frequent occurrence of primary hyper-
parathyroidism and osteoporosis in women in the menopause remains un-
explained. The relationship between other diseases and primary hyperpara-
thyroidism also seems to be a matter of chance. A developmental scheme 
for the histopathogenesis of the parathyroid tumors is given. 
Early diagnosis and treatment of hyperparathyroidism improves the 
prognosis. A description is therefore given of the pattern of symptoms and 
signs, which are composed of a highly variable number of components, in 
the hope of promoting the consideration of the possibility of hyperpara-
thyroidism in an early stage of the disease. For early diagnosis, however, 
the routine calcium determination is found to be eminently suitable. 
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Some ways to obtain confirmation of the diagnosis are also given. This 
usually boils down to the exclusion of other causes of hypercalcemia. 
Primary hyperparathyroidism is found predominantly in the age-group of 
30 to 65 years. It is a striking fact that the disease occurs twice as often in 
women over the age of 45 as in men of the same age. Before the 45th 
year there is no predilection for either sex. When determination of the 
plasma calcium level is done routinely, the number of identified cases of 
primary hyperparathyroidism increases. It is estimated that 1 to 3 per 
thousand of the total number of patients admitted to a hospital suffer from 
primary hyperparathyroidism. 
The surgical technique of the parathyroid exploration is designed primar-
ily to obtain an easily surveyed, i.e. a widely opened, bloodless surgical field. 
Damage to the recurrent laryngeal nerve is avoided by determining the 
course of this nerve initially. The nerve is also useful for locating the glands. 
The indications for a one-stage or a separate sternotomy in connection with 
the removal of expected mediastinal tumors are given. Retrosternal 
exploration via the cervical incision is advised. In this respect the thymus 
exploration is of fundamental importance, even when four glands have 
already been found. The importance of palpation of the thyroid gland and 
thyroidotomy for the exposure of intra-thyroidal tumors is pointed out. 
The indications for partial thyroidectomy are given. Total or subtotal 
thyroidectomy is considered to be a technical error. The secret of success 
in parathyroid exploration is based on three principles: 
1. All (four) glands must be exposed if possible. 
2. When a gland is found it must be carefully dissected in its entirety as 
far as the hilus, so that the size can be evaluated. It may only be consider-
ed enlarged on the basis of macroscopic appearance alone and not on the 
histological picture it shows. For these two points - the exposure and 
the evaluation - patience and experience are of paramount importance. 
3. Only after as many glands or tumors as possible have been dissected 
free, is a plan made for the resection. The details of this plan depend 
upon the number of glands found, the guarantee of good vascularization 
(vitality), and whether all the glands are enlarged or normal glands are 
also present. 
An exploration performed in this way will result in the lowest number 
of recurrences and the least aparathyroidism. 
Lastly, it may be mentioned that it is extremely important to record 
the findings made during an exploratory operation, for the event that 
re-exploration proves necessary. 
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In 255 of the 267 explored patients, parathyroid tumors were resected. A 
negative exploration was due to a mistaken diagnosis in only four cases, 
three concerning sarcoidosis and one 'pseudo-hyperparathyroidism'. Of the 
31 re-explorations in patients referred because of unsuccessful explorations, 
we also failed to find tumors in five cases, mainly due to marked fibrosis 
in the surgical field. This emphasizes the importance of finding all the glands 
at the first operation. 
The localization of the 939 glands found in our material is given. Of these, 
15.8% had a distinctly abnormal situation. We found partially or completely 
retrosternally located glands in 36% of our patients. This percentage 
exceeds all the values given in the literature, mainly due to the high number 
of intra-thymically situated glands. This localization can be expected in 
22.1% of the patients. Retrosternal tumors lying outside the thymus 
occur in 13.8% of the patients. Tumors with an abnormal localization far 
dorsally, e.g. behind the trachea and esophagus, were found only ten times. 
Such tumors almost always originate from the upper parathyroids. Intra-
thyroidally situated glands are to be expected in 5.5% of the patients. 
The surgical results obtained with the described technique may be called 
good for the patients who underwent their first exploration in our depart-
ment. Aside from the negative explorations caused by a wrong diagnosis, 
normocalcemia was obtained in the first instance in 99% of the cases, an 
average of 3.5 glands being found per patient. The results in referred pa-
tients were less satisfactory: re-exploration failed in 7 of these 31 cases 
(23%). 
Analysis of the origin of the tumors shows that in principle there is no 
preference in this respect for a given gland. This conclusion is in disagree-
ment with the data in the literature. It emphasizes, however, that all the 
glands must be located if the surgical treatment is to be successful, since the 
number and origin of the tumors is highly variable and unpredictable. There 
is a discrepancy between the number of tumors found by us per patient and 
the reported percentages of solitary adenomas and multiple adenomata in 
the literature. This may be explained by the fact that in primary hyper-
plasia not all the glands are affected per definition. 
In fifteen patients intra-thyroidal tumors were found. Normal glands 
were found in the thyroid gland twice. Regarded retrospectively, thyroido-
tomy seems to serve adequately for the detection of intra-thyroidal tumors. 
When a multinodular goiter is present, lobe resection may be required to 
obtain certainty concerning the presence of a small intra-thyroidal para-
thyroid gland. 
The results obtained with the surgical method described here, in 260 
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patients in whom primary hyperparathyroidism was demonstrated clinically 
and biochemically, were satisfactory. In 92.4% of the cases there was 
permanent euparathyroidism after the operation. In 4.2% a certain degree 
of hypercalcemia persisted. Three patients (1.2%) suffer from aparathy-
roidism as a result of the operation. 
There were few surgical complications. Only one patient now has a 
permanent unilateral paralysis of a vocal cord. In two cases a major blood 
vessel was damaged. All these complications were due mainly to fibrosis 
after prior operation elsewhere. Two patients developed pneumothorax in 
connection with a sternotomy, but this never occurred after retrosternal 
exploration through the cervical incision. 
One patient died post-operatively as the result of a hypercalcemic crisis, 
and one other of the consequences of the Zollinger-Ellison syndrome. 
To the best of our knowledge, only one of our patients has died of kidney 
damage caused by the hyperparathyroidism. 
Seven (3.1 %) of the patients first treated surgically by us developed a 
recurrence of the primary hyperparathyroidism. In the strict sense none of 
these cases can be called a true recurrence (i.e. enlargement of a previously 
normal gland); they are rather false recurrences caused by inadequate 
exploration and failure to excise a tumor. In view of the importance 
assigned here to this finding for the argumentation against preventive 
subtotal parathyroidectomy, the case histories of these patients are given. 
Thus, true recurrence is certainly rare. In our experience, too, after 
preventive subtotal parathyroidectomy a severe and prolonged hypocal-
cemia is seen fairly often. For these reasons we do not advocate this treat-
ment. 
As the result of an inadequately planned resection, three patients in this 
series now suffer from aparathyroidism. Because this endocrine mutilation 
is serious, the background of the errors made in these explorations are 
discussed. 
Finally, the dangers of the difficult to recognize post-operative hypopara-
thyroidism are discussed. 
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Samenvatting en condusies 
In dit proefschrift werden de gegevens van 267 patienten, waarbij een 
bijschildklierexploratie was verricht, geanalyseerd. Bij 255 van hen werd 
de diagnose primaire hyperparathyreoidie bij pathologisch-anatomisch onder-
zoek bevestigd. 
Aan de hand van gegevens nit de literatuur wordt het aantal normale 
bijschildklieren en hun ligging beschreven. Onze bevindingen wijken weinig 
af van die nit de literatuur. Bij een goed uitgevoerde exploratie worden 
meestal vier klieren gevonden, hetgeen met het toenemen van de ervaring 
steeds vaker gelukt. Voor een goed operatieresultaat moet men er echter 
rekening mee houden dat in 3-6% der gevallen meer dan vier klieren in 
totaal, of ook wei meer dan 2 klieren aan een zijde aanwezig zijn. De loca-
lisatie van de normale klieren wordt aangegeven: de bovenste bijschild-
klieren bevinden zich meestal tegen het schildklierachtervlak ter hoogte 
van de cartilage cricoidea, de onderste meestal aan de schildklieronderpolen. 
Vergrote klieren liggen verhoudingsgewijs vrijwel even vaak op de normale 
plaats als normale klieren. Vooral tumoren van de bovenste bijschildklieren 
lijken over een grote afstand naar caudaal en dorsaal zelfs tot in het medi-
astinum posterius te kunnen migreren. Tenslotte wordt gewezen op de 
mogelijkheden en beperkingen om een bijschildkliertumor via de vaatsteel, 
uitgaande van de arteria thyreoidea inferior te kunnen localiseren. 
Ret is niet gelukt de betekenis en de functionele activiteit van de ver-
schillende celtypen (hoofdcel, transitionele eel, waterheldere eel en oxyphiele 
eel) te achterhalen. De opbouw van het parenchym wisselt sterk met de 
leeftijd en de activiteit van de bijschildklier. De kennis om trent het voor een 
bepaalde leeftijd normale beeld is noodzakelijk om de histologische grens 
tussen normale en pathologische klieren te kunnen maken. 
Na een korte bespreking van de fysiologie van het parathyreoid hormoon 
en het calcitonine wordt de pathologische anatomic beschreven. De laatste 
tien jaren blijkt het enkelvoudig adenoom iets minder vaak gevonden te 
worden. Steeds vaker wordt een vorm van de primaire hoofdcellen hyper-
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plasie gediagnostiseerd. Multipele adenomata en primaire waterheldere 
cellen hyperplasie wordt weinig meer gevonden. Bij de bestudering van de 
maatstaven, welke voor de verschillende beelden zijn gehanteerd blijkt 
echter dat de vroegere absolute criteria voor het onderscheid van deze 
beelden de laatste jaren steeds minder worden aangehouden: Het randje 
normaal weefsel wordt niet alleen bij adenomen, doch oak bij hyperplastische 
klieren gevonden. Verder kan een normale klier niet alleen bij adenomata, 
doch oak bij primaire hyperplasie worden gevonden. De differentia tie tussen 
adenomen en vooral de nodulaire hyperplasie is dan oak vrijwel onmogelijk 
en sterker nog: het verschil tussen pathologisch en normaal weefsel is nogal 
eens niet aan te geven. Voor de chimrg is het histologisch onderzoek bij de 
operatie echter onmisbaar om verwarring tussen bijschildklier-, schildklier-, 
thymus- en lymfeklierweefsel te voorkomen. 
Het probleem van de pathogenese van de primaire hyperparathyreoidie 
wordt beheerst door twee kernpunten: De enige ons bekende bijschildklier-
stimulus is hypocalciaemie. Bij hypercalciaemie worden hyperplatische 
klieren, welke histologisch dus geen autonome functie lijken te hebben 
gevonden. Voor dit fenomeen wordt een theoretische verklaring gezocht. 
Aangezien de tertiare hyperparathyreoidie herhaaldelijk is beschreven, 
wordt getracht ook bij de primaire hyperparathyreoidie een fase van 
(geringe) hypocalciaemie door niet externe oorzaken, op te sporen. Schild-
klieraandoeningen blijken opvallend vaak als concommitterende ziekten te 
worden gevonden. Het is niet duidelijk in hoeverre hypothyreoidie en hyper-
parathyreoidie oorzakelijk verband met elkaar houden. Hypercalcitoninisme, 
acrmnegalie, hyperglucagonaemie en pancreatitis geven mogelijk aanleiding 
tot secundaire en tertiaire hyperparathyreoidie. In dit licht bezien is de auto-
nome hyperparathyreoidie zoals die gevonden wordt bij multipele endocriene 
adenomatose mogelijk tertiair, hoewel bij deze laatste ziekte en bij hyper-
parathyreoidie alleen gezien het familiaire voorkomen van beiden een 
genetische fout een rol kan spelen. De parallel van het frequenter voorkomen 
van primaire hyperparathyreoidie en osteoporose bij vrouwen in de meno-
pauze blijft onverklaarbaar. Ook de relatie tussen andere ziekten en primaire 
hyperparathyreoidie lijkt een toevallige. Tenslotte wordt een ontwikkelings-
schema voor de histopathogenese van de bijschildkliertumoren gegeven. 
Een vroege diagnose en therapie van de hyperparathyreoidie begunstigt 
de prognose. Daarom wordt het klachtenpatroon en de symptomatologie 
welke samengesteld zijn uit een zeer variabel aantal compomenten be-
schreven. Dit in de hoop de gedachte aan hyperparathyreoidie in een vroeg 
stadium te doen opkomen. De routine calciumbepaling lijkt daarvoor echter 
het meest geschikt. Tevens worden enkele richtlijnen ter verificatie van de 
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diagnose aangegeven. J\!Ieestal komt dit neer op het uitsluiten van andere 
oorzaken van hypercalciaemie. 
Primaire hyperparathyreoidie wordt vooral in de leejtijdsgroep van 30-65 
jaar gevonden. Opvallend is, zoals reeds gezegd het feit, dat de ziekte 
tweemaal vaker bij vrouwen hoven het 45e jaar wordt gevonden dan bij 
mannen van dezelfde leeftijd. Voor het 45e jaar is de verdeling over beide 
geslachten gelijk. Bij invoering van het plasma calcium als routinebepaling 
stijgt het aantal gevonden lijders aan primaire hyperparathyreoidie per jaar. 
Naar schatting lijden 1-3%0 van het totale aantal patienten welke een zieken-
huis bezoeken aan primaire hyperparathyreoidie. 
De operatietechniek van de bijschildklierexploratie is primair gericht op 
een goed overzichtelijk, dus ruim opengelegd operatieterrein, waarin bloed-
verlies uit den boze is. Beschadiging van de nervus laryngeus recurrens 
wordt voorkomen door het verloop van deze zenuw voor alles te vervolgen. 
De zenuw is tevens van waarde voor het localiseren van de klieren. De 
indicaties tot eenstaps sternotomie en sternotomie in een afzonderlijke 
operatic voor te verwachten mediastinale tumoren wordt aangegeven. 
Retrosternale exploratie vanuit de cervicale incisie wordt geadviseerd. 
Daarbij is de thymus exploratie van essentieel belang, ook a! werden reeds 
vier klieren gevonden. Er wordt gewezen op het belang van de schildklier-
palpatie en de thyreoidotomie ter ontsluiting van intrathyreoidale tumoren. 
De indicaties voor partiCle thyreoidectomie worden aangegeven. Totale 
thyreoidectomie wordt als een kunstfout beschouwd. Ret geheim van het 
succes van de bijschildklierexploratie is gegrondvest op drie principes: 
a) Alle (vier) klieren moeten zo mogelijk a vue worden gebracht. 
b) Gevonden klieren moeten voorzichtig in hun geheel tot aan de hilus 
worden vrijgeprepareerd om hun omvang te kunnen overzien. Daarna 
wordt pas beslist of de klieren vergroot zijn of niet. Hierbij wordt alleen 
afgegaan op het macroscopische aspect en niet op de histologische op-
bouw van de klier. Voor deze twee punten is geduld en ervaring een 
eerste vereiste. 
c) Pas nadat zoveel mogelijk klieren c.q. tumoren zijn vrijgeprepareerd 
wordt een resectieplan opgemaakt. De uitwerking hiervan berust op het 
gevonden aantal klieren, de waarborg voor een goede vascularisatie 
(vitaliteit) en of zij alle vergroot zijn, of dat er normale klieren aanwezig 
zijn. Een op deze wijze uitgevoerde exploratie resulteert in het kleinste 
aantal recidieven en de minste aparathyreoidien. 
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Tenslotte wordt gewezen op het grote belang de bevindingen bij exploratie 
nauwkeurig aan te geven in verband met een eventuele reexploratie. 
Bij 255 van de 267 geexploreerde patienten werden bijschildkliergezwellen 
gereseceerd. Slechts viermaal werd een negatieve exploratie veroorzaakt 
door een font in de diagnose: driemaal sarcoidosis en eenmaal door 'psendo-
hyperparathyreoidie'. Van de 31 reexploraties bij patienten waar reeds 
elders de opera tie was mislnkt kon ook door ons vijfmaal geen sncces worden 
geboekt vooral door sterke fibrose van het operatieterrein. Dit benadrukt de 
noodzaak om reeds bij de eerste opera tie een volledig sncces te boeken. 
De localisatie van de 939 gevonden klieren wordt aangegeven. Hiervan 
waren er 15,8% op een dnidelijk abnormale plaats gelegen. Door ons werd 
bij 36% der patienten gedeeltelijk of geheel retrosternaal gelegen klieren 
gevonden. Dit percentage overtreft alle andere in de literatnnr gegeven 
getallen. Dit wordt voornamelijk veroorzaakt door de grote hoeveelheid 
intrathymisch gevonden klieren. Deze localisatie valt bij 22,1% der patienten 
te verwachten. Retrosternale klieren bniten de thymus komen bij 13,8% 
van de patienten voor. Abnormaal ver naar dorsaal gelegen klieren zoals 
achter de trachea en oesophagus troffen wij slechts tienmaal aan. Deze gaan 
praktisch altijd uit van de bovenste bijschilklieren. Intrathyreoidale klieren 
moet men bij 5,5% der patienten verwachten. 
De technische operatieresultaten van de beschreven techniek waren bij de 
patienten, welke hun eerste exploratie bij ons ondergingen zonder meer 
goed. Afgezien van de negatieve exploraties, veroorzaakt door een fout in 
de diagnose werd in 99% der gevallen in eerste instantie een normocalciaemie 
bereikt. Er werden dan ook per patient gemiddeld 3I klieren gevonden. De 
resultaten bij de patienten, welke ons na een mislukking elders waren toe-
gestuurd waren minder gunstig: Bij 7 van hen (23%) mislukte de reex-
ploratie. 
Bij analyse van de oorsprong der tumoren blijkt, dat er in principe geen 
voorkeur is voor een ontaarding van een bepaalde klier. Dit in tegenstelling 
tot de gegevens uit de literatuur. Tevens wordt nogmaals duidelijk, dat alle 
klieren opgezocht moeten worden om succes te boeken: Het aantal tumoren 
en hun afkomst is zeer wisselend en onvoorspelbaar. 
Er blijkt een discrepantie te bestaan tussen het door ons gevonden aantal 
tumoren per patient en de opgaven van het percentage enkelvoudige 
adenomata en mnltipele adenomata in de literatuur. Mogelijk is de ver-
klaring hiervan, dat bij de primaire hyperplasie niet per definitie alle 
klieren zijn aangedaan. 
Voor het localiseren en de resectie van de tumoren was sternotomie slechts 
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bij 3 patienten noodzakelijk. Deze tumoren lagen alle meer dan 5 em onder 
de sternumrand. Gezien het grote aantal retrosternale klieren en het geringe 
aantal sternotomien blijkt het grote bclang van de rdrosternale exploratie 
vanuit de halsincisie overduidelijk. Vijfmaal werd een sternotomie op 
foutieve grond verricht. 
Bij 15 patientcn werden intrathyreoidale tumoren gevonden. Tweemaal 
troffen wij normale klieren in de schildklier aan. Retrospectief gezien lijkt 
de thyreoidotomie afdoende voor het opsporen van de intrathyreoidale 
tum oren. K wabsresectie kan, vooral wanneer er een 1nultinodulair struma 
bestaat, noodzakelijk zijn orn zekerheid te verkrijgen om trent de aanwezig-
heid van een kleine intrathyreoidale bijschildklier. 
Het resultaat van de operatic bij 260 patienten waarbij primaire hyper-
parathyreoidie op klinische en biochemische gronden vaststaat is wanneer 
de reeds beschreven techniek wordt gevolgd gunstig. In 92,4% der gevallen 
ontstond na operatic een blijvende euparathyreoidie. Bij 4,2% der patienten 
bleef een zekere mate van hypercalciaemie bestaan. Drie patienten 
(1,2%) werden door de operatic aparathyreoot. 
Er waren weinig operatieve complicaties. Slechts een patient heeft een 
eenzijdige blijvende paralyse van de nervus laryngeus recurrens. Tweemaal 
werd een belangrijk vat beschadigd. Deze complicaties zijn vooral het 
gevolg van fibrose in het operatieterrein. Tweemaal ontstond een pneumo-
thorax in aansluiting op een sternotomie, doch nimmer na retrosternale 
exploratie via de halsincisie. 
Een patient overleed postoperatief door een hypercalciaemische crisis, 
een andere patient aan de gevolgen van het Zollinger-Ellison syndroom. 
Tot dusver bekend overleed slechts een van onze patienten aan de door 
de hyperparathyreoidie veroorzaakte nierbeschadiging. 
Bij 7 (3,1 %) van de in eerste instantie door ons geopereerde patienten 
werd een recidief van de primaire hyperparathyreoidie gevonden. In strikte 
zin is bij geen van hen sprake van een werkelijk recidief (dat wil zeggen 
door uitgroei van een tevoren nonnale klier) doch van een vals recidief 
(wat wordt veroorzaakt door het achterblijven van een tumor bij een 
insufficiente exploratie). Gezien het belang van deze bevinding voor de te 
ontraden zogenaamde preventieve subtotale parathyreoidectomie worden 
de ziektegeschiedenissen van deze patienten bediscussieerd. Het werkelijke 
recidief is dus zeldzaam. Verder treedt volgens onze ervaring na de preven-
tieve subtotale parathyreoidectomie nogal eens een ernstige en langdurige 
hypocalciaemie op. Om deze redenen zijn wij geen voorstanders van deze 
techniek. 
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Door een ondoordacht resectieplan lijden thans nag drie patienten aan 
aparathyreoidie. Gezien de ernst van deze endocriene rnutilatie worden de 
achtergronden van de fouten van deze exploraties weergegeven. 
Tenslotte wordt gewezen op de gevaren van de rnoeilijk te herkennen 
postoperatieve hypoparathyreoidie. 
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